Perelman School of Medicine at the University of Pennsylvania

Center for Preventive Ophthalmology and Biostatistics (CPOB)

CPOB Publications

The following is a list of publications produced by CPOB staff and study colleagues.

DREAM Study Publications

2015

Hom MM, Asbell P, Barry B. Omegas and dry eye: More knowledge, more questions.  Optom Vis Sci 2015;92:948-56.

2017

Roy NS, Wei Y, Kuklinski E, Asbell PA. The growing need for validated biomarkers and endpoints for dry eye clinical research. Invest Ophthalmol Vis Sci 2017;58:BIO1–BIO19.  PMC5455411

2018

The Dry Eye Assessment and Management Study Research Group.  n-3 fatty acid supplementation for treatment of dry eye disease. N Engl J Med 2018;378:1681-1690. Epub 2018 Apr 13.  PMC5952353.

Asbell PA, Maguire MG, Peskin E, Kuklinski E, Bunya VT, the DREAM Study Research Group. The Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.  Contemp Clin Trials 2018; 71:70-79. PMC7250048

Bunya VY, Ying G-S, Maguire MG, Kuklinski E, Lin M, Peskin E, Asbell PA, DREAM Study Research Group. Prevalence of novel candidate Sjogren's Syndrome antibodies in the Dry Eye Assessment and Management (DREAM©) Study. Cornea 2018;37:1425-1430.  Epub 2018 Aug 29. PMC6173620.

2019

Daniel E, Maguire MG, Pistilli M, Bunya VY, Massaro-Giordano GM, Smith E, Kadakia PA, Asbell PA, the Dry Eye Assessment and Management Study.  Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) Study. Ocul Surf 2019;17:491-501. Epub 2019 Apr 22. PMC6708483.

Szczotka-Flynn LB, Maguire MG, Ying G-S, Lin MC, Bunya VY, Dana R, Asbell PA. Impact of dry eye on visual acuity and contrast sensitivity: Dry Eye Assessment and Management Study.  Optom Vis Sci 2019;96:387-96. Epub 2019 May 20.  PMC6544497.

Oydanich M; Maguire MG, Pistilli M; Hamrah P, Greiner JV, Lin MC, Asbell PA, the Dry Eye Assessment and Management (DREAM) Study Research Group. Effects of omega-3 supplementation on exploratory outcomes in the DREAM Study. Ophthalmology 2020;127:136-37.  Epub 2019 Jul 25. PMC6926153.

Hussain M, Shtein RM, Pistilli M, Maguire MG, Oydanich M, Asbell PA, DREAM Research Group. The Dry Eye Assessment and Management (DREAM) extension study – A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease. Ocul Surf 2020;18:47-55. Epub 2019 Aug 16.  PMC7004875.

Roy NS, Wei Y, Yu Y, Ying G-S, Kuklinski E, Barry B, Maguire MG, Dana R, Brightwell-Arnold M, Asbell PA, Dry Eye Assessment and Management (DREAM) Study Group. Conjunctival HLA-DR expression and its association with symptoms and signs in the DREAM study. Transl Vis Sci Technol 2019;8(4):31. PMC6707226.

2020

Kuklinski EJ, Hom MM, Ying GS, Lin MC, Chapkin R, Jones R, Moser A, Kim KY, Maguire  MG, Asbell PA. Associations between systemic omega-3 fatty acid levels with moderate to severe dry eye disease signs and symptoms at baseline in the Dry Eye Assessment and Management Study.  Eye Contact Lens 2021;47:2-7. Epub 2020 Feb 24. PMC7483206.

Berg EJ, Ying GS, Maguire MG, Sheffield PE, Szczotka-Flynn LB, Asbell PA, Shen JF, the DREAM Study Research Group. Climatic and environmental correlates of dry eye disease severity: A report from the Dry Eye Assessment and Management (DREAM) Study.  Transl Vis Sci Technol 2020;9(5):25. PMC7401914.

Daniel E, Pistilli M, Ying G-S, Bunya VY, Massaro-Giordano M, Asbell PA, Maguire MG. Association of Meibomian gland morphology with symptoms and signs of dry eye disease in the Dry Eye Assessment and Management (DREAM) Study.  Ocul Surf 2020;18:761-769. Epub 2020 Aug 25.

Greco G, Pistilli M, Asbell PA, Maguire MG, the Dry Eye Assessment & Management (DREAM) Study Research Group. Association of severity of dry eye disease with work productivity and activity impairment in the Dry Eye Assessment & Management Study. Ophthalmology 2021; 128:850-856. Epub 2020 14 Oct 14.

2021

Sayegh RR, Yu Y, Farrar JT, Kuklinski E, Shtein RM, Asbell PA, Maguire MG, the Dry Eye Assessment and Management (DREAM) Study Research Group. Ocular discomfort and quality of life among patients in the Dry Eye Assessment and Management (DREAM) Study. Cornea. 2021;7:869-875. 

Yu K, Bunya V, Maguire M, Asbell P, Ying G-S. Systemic conditions associated with severity of dry eye signs and symptoms in the Dry Eye Assessment and Management (DREAM) Study. Ophthalmology. 2021 Mar 27;S0161-6420(21)00235-9. doi: 10.1016/j.ophtha.2021.03.030. Online ahead of print.

Sutphin JE, Ying Correlation GS, Bunya VY, Yu Y, Lin MC, McWilliams K, Schmucker D, Kuklinski EJ, Asbell PA, Maguire MG. Association of keratographic and clinical Assessments of dry eye disease in the DRy Eye Assessment and Management (DREAM) Study. Cornea.  Cornea. 2021 Jul 22. doi: 10.1097/ICO.0000000000002804. [Online ahead of print]. PMID: 3429463

Close


G-ROP Publications

  1. Binenbaum G, Tomlinson L, on behalf of the G-ROP Study Group: Postnatal Growth and Retinopathy of Prematurity Study: Rationale, Design, and Subject Characteristics. Ophthalm Epid 2017; 24(1): 36-47.
  2. Gurwin J, Tomlinson LA, Quinn GE, Ying GS, Baumritter A, Binenbaum G, on behalf of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group and the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Cooperative Group: A Tiered Approach to Retinopathy of Prematurity Screening (TARP) Using a Weight Gain Predictive Model and a Telemedicine System. JAMA Ophthalmol. 2017;135(2):131–136.

  3. Binenbaum G, Ying GS, Tomlinson LA; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model. JAMA Ophthalmol. 2017;135(8):871-877.

  4. Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, Ying GS; G-ROP Study Group. Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study. JAMA Ophthalmol. 2018;136(9):1034-1040.

  5. Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G; G-ROP Study Group. Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA Ophthalmol. 2018;136(12):1383-1389.

  6. Morrison D, Shaffer J, Ying GS, Binenbaum G; G-ROP Study Group. Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. J AAPOS. 2018;22(2):128-133.

  7. McCourt EA, Ying GS, Lynch AM, Palestine AG, Wagner BD, Wymore E, Tomlinson LA, Binenbaum G; G-ROP Study Group. Validation of the Colorado Retinopathy of Prematurity Screening Model. JAMA Ophthalmol. 2018;136(4):409-416.

  8. Bal S, Ying GS, Tomlinson L, Binenbaum G; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Association of Weight Gain Acceleration With Risk of Retinopathy of Prematurity. JAMA Ophthalmol. 2019;137(11):1301-1305.

  9. Liu T, Tomlinson LA, Ying GS, Yang MB, Binenbaum G; G-ROP Study Group. Treatment of non-type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study. J AAPOS. 2019;23(6):332.e1-332.e6.

  10. Ying GS, Bell EF, Donohue P, Tomlinson LA, Binenbaum G; G-ROP Research Group. Perinatal Risk Factors for the Retinopathy of Prematurity in Postnatal Growth and Rop Study. Ophthalmic Epidemiol. 2019;26(4):270-278.

  11. Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, Quinn GE, Repka MX, Rogers D, Yang MB, Yu Y, Ying GS; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria. JAMA Ophthalmol. 2020;138(1):31-37.

  12. Zupancic JAF, Ying GS, de Alba Campomanes A, Tomlinson LA, Binenbaum G; G-ROP Study Group. Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study. J Perinatol. 2020;40(7):1100-1108.

  13. Yu Y, Tomlinson LA, Binenbaum G, Ying GS; G-Rop Study Group. Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort. Br J Ophthalmol. 2020 Sep 26:bjophthalmol-2020-317467.

  14. Lin LY, Jensen AK, Quinn GE, Spiller A, Tomlinson LA, Ying GS, Binenbaum G. Symmetry of Disease in Retinopathy of Prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. Ophthalmic Epidemiol. 2020;27(6):477-481.

  15. Flannery DD, Jensen EA, Tomlinson LA, Yu Y, Ying GS, Binenbaum G; Postnatal Growth and ROP (G-ROP) Study Group. Poor postnatal weight growth is a late finding after sepsis in very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2021;106(3):298-304.

  16. Barry GP, Yu Y, Ying GS, Tomlinson LA, Lajoie J, Fisher M, Binenbaum G; G-ROP Study Group. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmology. 2021;128(8):1188-1196.

Close


Age-Related Macular Degeneration And Thalidomide Study (AMDATS) Publications

SL Fine, MG Maguire, AM Maguire, RJ D’Amato, LJ Singerman, the AMDATS Research Group. Results of the Age-Related Macular Degeneration and Thalidomide Study (AMDATS) Investigative Ophthalmology and Visual Science March 2001, Vol 42, Abstract 1255.

Close


Age-related Macular Degeneration and Radiotherapy Trial (AMDRT) Publications

The AMDRT Research Group. The Age-Related Macular Degeneration Radiotherapy Trial (AMDRT): One Year Results from a Pilot Study American Journal of Ophthalmology, 2004; 138:818-828. Article

Marcus, DM. Peskin, E. Alexander, JA. Weissgold, G. Maguire, MG Maguire, AM. Fine, SL. The Age-Related Macular Degeneration Radiotherapy Trial(AMDRT): 1 Year Results Investigative Ophthalmology and Visual Science, 2003; 44: E-Abstract 3158.

Maguire MG. Maguire, AM. Fine SL. and the AMDRT Study Group. The Age-related Macular Degeneration Radiotherapy Trial (AMDRT): Baseline Characteristics Investigative Ophthalmology and Visual Science, 2002; 43: E-Abstract 1207.

Close


Biostatistics Module Publications - Since September 2000

2000

Volpe NJ, Plotkin ES, Maguire MG, Hariprasad R, Galetta SL. Portable pupillography of the swinging flashlight test to detect afferent pupillary defects. Ophthalmology 2000; 107:1913-1921. Article

Balcer LJ, Baier  ML, Kunkle AM, Rudick  RA, Weinstock-Guttman B, Simonian N, Galetta SL, Cutter GR, Maguire MG. Self-Reported Visual Dysfunction in Multiple Sclerosis: Results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). Multiple Sclerosis 2000; 6:382-385. Article

2001

Kaiser RS, Berger JW, Maguire MG, Shin DS, Ho AC, Javornik NB, Fine SL and the Choroidal Neovascularization Prevention Trial Research Group. Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Archives of Ophthalmology 2001; 119:826-832. Abstract

Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Investigational Ophthalmology Visual Science2001; 42:1873-1881. Article

Stone RA, Lin T, Sugimoto R, Capehart C, Maguire MG, Schmidt GF. Corneal surface area: an index of anterior segment growth. Ophthal Physiol Opt 2001; 21:286-295. Article

Aleman TS, LaVail MM, Montemayor R, Ying GS, Maguire MG, Laties AM, Jacobson SG, Cideciyan AV. Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats. Vision Research 2001; 2779-2797. Article

Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG. Visual loss in children with neurofibromatosis type-1 and optic pathway gliomas: Relation to tumor location by MR imaging. American Journal of Ophthalmology 2001; 131:442-445. Article

2002

Loman J, Quinn GE, Kamoun L, Ying GS, Maguire MG, Hudesman D, Stone RA. Darkness and near work: Myopia and its progression in third-year law students. Ophthalmology 2002; 1032-1038. Article

Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology 2002: 109:1235-1242. Article

Ma SL, Shea JA, Galetta SL, Jacobs DA, Markowitz CE, Maguire MG, Balcer LJ. Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. American Journal of Ophthalmology 2002; 686-692. Abstract

Duncan JL, Aleman TS, Gardner LM, De Castro E, Marks DA, Emmons JM, Bieber ML, Steinberg JD, Bennett J, Stone EM, MacDonald IM, Cidediyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in choroideremia. Experimental Eye Research 2002; 74:371-381. Article

Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Archives of Ophthalmology 2002; 120:1435-1442. Abstract

2003

Hahn P, Lindsten T, Ying GS, Bennett J, Milam AH, Thompson CB, Dunaief JL. Proapoptotic Bcl-2 family members, Bax and Bak, are essential for developmental photoreceptor apoptosis. Investigational Ophthalmology & Visual Science 2003; 44:3598-3605. Article

Lee MS, Balcer LJ, Volpe NJ, Liu GT, Ying GS, Galetta SL. Laser pointer visual field screening. Neuroophthalmology 2003; 23:260-263. Abstract

Quinn GE, Francis EL, Nipper KS, Flitcroft DI, Ying GS, Rees R, Schmid G, Maguire MG, Stone RA. Highly precise eye length measurements in children ages 3-12 years. Archives of Ophthalmology 2003; 121:985-990. Abstract

Prenner JL, Rosenblatt BJ, Tolentino MJ, Ying GS, Javornik NB, Maguire MG, Ho AC, the CNVPT Research Group. Risk factors for choroidal neovascularization and vision loss in the Fellow Eye Study of CNVPT. Retina 2003; 23:307-314. Abstract

Javitt JC, Zhou, Z, Maguire MG, Fine SL, Willke RJ. Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology 2003; 110:1534-1539. Article

Vannas AE, Ying GS, Stone RA, Maguire MG, Jormanainen V, Tervo T. Myopia and natural lighting extremes: risk factors in Finnish army recruits. Acta Ophthalmology Scandinavian 2003; 81:588-595. Article

Balcer LJ, Baier ML, Cohen JA, Kooijmans MF, Sandrock AW, Nano-Schiavi L, Pfohl DC, Mills M, Bowen J, Ford C, Heidenreich FR, Jacobs DA, Markowitz CE, Stuart WH, Ying GS, Galetta SL, Maguire MG, Cutter CR. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology 2003; 61:1367-1373. Article

2004

Stone RA, Quinn GE, Francis EL, Ying GS, Flitcroft DI, Parekh P, Brown J, Orlow J, Schmid G. Diurnal axial length fluctuations in human eyes. Investigational Ophthalmology & Visual Science 2004; 45:63-70. Article

Tolentino MJ, Brucker AJ, Fosnot J, Ying GS, Wu IH, Malik G, Wan S, Reich SJ. Intravitreal injection of VEGF siRNA inhibits growth and leakage in a non-human primate laser induced model of CNV. Retina 2004; 24:132-138. Abstract

Ibarra MS, Hsu J, Mirza N, Wu I-H, Ying GS, Mainster MA, Tolentino MJ. Retinal temperature increase during transpupillary thermotherapy: effects of pigmentation, subretinal blood, and choroidal blood flow. Investigational Ophthalmology & Visual Science 2004; 45:3678-3682. Article

Hahn P, Lindsten T, Lyubarsky A, Ying GS, Pugh EN, Thompson CB, Dunaief JL. Deficiency of Bax and Bak protects photoreceptors from light damage in vivo. Cell Death and Differentiation 2004; 11:1192-1197. Article

Metelisina TI, Grunwald JE, Dupont JC, Ying GS. Effects of Niacin on the choroidal circulation of patients with Age-related Macular Degeneration (AMD). BritishJournal of Ophthalmology 2004; 88:1568-1572. Article

2005

Metelitsina TI, Grunwald JE, DuPont JC, Ying GS. Effect of Viagra on the ocular circulation of AMD patients. Experimental Eye Research 2005, 81:159-64. Article

Roman AJ, Schwartz SB, Alman TS, Cideciyan AV, Chico JD, Windsor E, Gardner LM, Ying GS, Smilko EE, Maguire MG, Jacobson SG. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Experimental Eye Research 2005; 80:259-272. Article

Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Maguire MG. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Investigational Ophthalmology & Visual Science 2005; 46:1033-1038. Article

Heidary G, Ying GS, Maguire MG, Young TL. The association of astigmatism and spherical refractive error in a high myopia cohort. Optometry & Visual Science 2005, 82:244-247. Abstract

Kupersmith MJ, Ying GS. Ocular motor dysfunction in ocular myasthenia gravis: effects of treat. British Journal of Ophthalmology. 2005 Oct;89(10):1330-4. Article

2006

Pineles S, Volpe NJ, Miller-Ellis E, Galetta SL, Sankar PS, Shindler KS, Maguire MG. Automated combined kinetic and static perimetry: An alternative to standard perimetry in neuro-ophthalmic and glaucoma patients. Archives of Ophthalmology 2006; 124:363-369. Article

Metelitsina TI, Grunwald JE, DuPont JC, Ying GS. Effect of systemic hypertension on foveolar choroidal blood flow in age rated macular degeneration (AMD). British Journal of Ophthalmology 2006; 90:342-346. Article.

Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Liu CC. Effect of Viagra on the retinal vein diameter in AMD patients. Experimental Eye Research 2006; 83:128-132. Article

Wilson LB, Quinn GE, Ying GS, Francis EL, Schmid G, Lam A, Orlow J, Stone RA. The relation of axial length and intraocular pressure fluctuations in human eyes. Invest Ophthalmol Vis Sci 2006; 47:1778-84. Article

Komaromy AM, Garg CD, Ying GS, Liu CC. The effect of head position on intraocular pressure in horses. American Journal of Veterinary Research 2006; 67:1232-5. Article

Stone RA, Wilson LB, Ying GS, Liu CC, Criss JS, Orlow J, Lindstrom JM, Quinn GE. Associations between Childhood Myopia and Parental Smoking. Invest Ophthalmol Vis Sci 2006; 47:4277-87. Article

Tania TY, Mills MD, Beck AD, Joos KM, Ying GS, Liu CC, Piltz-Seymour JR. Central Corneal Thickness and Corneal Diameter in Patients with Childhood Glaucoma. Journal of Glaucoma 2006; 15:524-8. Abstract

Raphael BA, Galetta KM, Jacobs DA, Markowitz CE, Liu GT, Nano-Schiavi ML, Galetta SL, Maguire MG, Mangione CM, Globe DR, Balcer LJ. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol. 2006;142:1026-35. Article

Fisher, JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, WInslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113:324-32. Article

Hahn P, Ying GS, Beard J, Dunaief JL. Iron levels in human retina: sex difference and increase with age. Neuroreport 2006; 17:1803-6. Article

2007

Rabinowitz MP, Grunwald JE, Karp KA, Quinn GE, Ying GS, Mills MD. Progression to severe retinopathy predicted by retinal vessel diameter between 31 and 34 weeks of postconception age. Archives of Ophthalmology 2007;125:1495-500. Article

Orlin A, Mills MD, Ying GS, Liu CC. A Comparison of Hang-Back with Conventional Recession Surgery for Exotropia. J AAPOS 2007; 11:597-600. Abstract

Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, Biousse V, Lee AG, Wall M, Kardon R, Acierno MD, Corbett JJ, Maguire MG, Balcer LJ. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007; 143:635-41. Article

2008

Metelitsina TI, Grunwald JE, Dupoint JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in Age-related Macular Degeneration. Invest Ophthalmol Vis Sci 2008; 49:358-63. Article

Greller AL, Hoffman AB, Liu C, Ying GS, Vudathala D, Acland GM, Komáromy AM. Effects of the topically applied calcium-channel blocker flunarizine on intraocular pressure in clinically normal dogs. Am J Vet Res 2008; 69:273-8. Article

Ranchod TM, Guercio JR, Ying GS, Brucker AJ, Stoltz RA. Effect of aspirin therapy on photodynamic therapy with verteporfin for choroidal neovascularization. Retina 2008; 28:711-6. Abstract

Skalet AH, Quinn GE, Ying GS, Gordillo L, Dodobara L, Cocker K, Fielder AR, Ells AL, Mills MD, Wilson C. Gilbert C. Telemedicine screening for Retinopathy of Prematurity (ROP) in developing countries using digital retinal images: A feasibility project. J AAPOS 2008; 12:252-8. Abstract

Zaveri M, Conger A, Salter A, Frohman TC, Galetta SL, Markowitz CE, Jacobs DA, Cutter GR, Ying GS, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM. Retinal Imaging by Laser Polarimetry and Optical Coherence Tomography Evidence of Axonal Degeneration in Multiple Sclerosis. Archives of Neurology 2008; 65:924-8. Article

Maguire AM, Simonelli F, Pierce EA, Pugh EN, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Serace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell’Osso L, Hertle R, Ma J, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J. Safety and efficacy of gene transfer for Leber’s congential amaurosis. N Engl J Med 2008; 358;2240-8. Article

Ying GS, Maguire MG, Liu CC, Antoszyk A, and Complications of Age-related Macular Degeneration Prevention Trial Research Group. Night vision and progression of Age-related Macular Degeneration (AMD) in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology 2008; 115:1876-82. Article

Jefferys JL, Alexander J, Hiner CJ, Javornik NB, Smith RE, Bressler NM, Hawkins BS, Maguire MG. Reproducibility of gradings of retinal photographs in eyes with subfoveal choroidal neovascularization and age-related macular degeneration in the Macular Photocoagulation Study. Ophthalmic Epidemiology 2008; 15:191-201. [PMID: 18569815].

Maguire MG, Alexander J, Fine SL, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Characteristics of choroidal neovascularization in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2008;115:1468–1473 Epub 2008 May 15. [PMID: 18486222]

Umscheid CA, Maguire MG, Pines JM, Everett WW, Baren JM, Townsend RR, Mines D, Szyld D, Gross, R. Untreated hypertension and the emergency department: a chance to intervene? Acad Emerg Med 2008; 15:529-36. [PMID: 18616438]

2009

Brown JS, Flitcroft DI, Ying GS, Francis EL, Quinn GE, Stone RA. In Vivo human choroidal thickness measurements: Evidence of diurnal fluctuations. IOVS 2009; 50:5-12. Article

Lukinova N, Iacovelli J, Dentchev T, Wolkow N, Hunter A, Amado D, Ying GS, Sparrow J, Dunaief JL. Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli. IOVS 2009; 50:1440-7. Article

Ranchod TM, Brucker AJ, Liu CC, Cukras CA, Hopkins TB, Ying GS. Evaluation of actual versus expected PDT spot size. Am J Ophthalmol. 2009; 147:859-64. 

Friedman DS, Okeke CO, Jampel HD, Plyler RJ, Ying GS, Jiang YZ, Quigley HA. Risk factors of poor adherence with eyedrops in electronically monitored glaucoma patients. Ophthalmology 2009; 116:1097-1105. Article

Okeke CO, Quigley HA, MD, Jampel HD, Plyler RJ, Ying GS, Friedman DS. Adherence with Topical Glaucoma Medication Monitored Electronically: the Travatan Dosing Aid (TDA) Study. Ophthalmology 2009; 116:191-9. Article

Ying GS, Maguire MG, Alexander J, Martin R, Antoszyk A. Description of the AREDS 9-step severity scale applied to participants in CAPT. Archives of Ophthalmology 2009; 127:1147-51. Article

Maguire MG, Ying GS, McCannel C, Liu CC. Dai Y. Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2009; 116:2381-5. Article

Grunwald L, Mills MD, Johnson K, Karp KA, Quinn GQ, Ying GS, Grunwald JE. Does change in retinal vessel diameter over time predict severe retinopathy of prematurity? Am J of Ophthalmol 2009; 147:1086-1091.

Hahn P, Song Y, Ying GS, He X, Beard J, Dunaief JL. Age-dependent and gender-specific changes in mouse tissue iron by strain. Experimental Gerontology 2009; 44:594-600. Article

Iacovelli J, Mlodnicka AE, Veldman P, Ying GS, Dunaief JL, Schumacher A. Brain and retinal ferroportin 1 dysregulation in polycythaemia mice. Brain Res. 2009; 1289:85-95. Article

Shah DN, Wilson C, Ying GS, Karp K, Fielder A, Ng J, Mills MD, Quinn GE. Semiautomated digital image analysis of posterior pole vessels in retinopathy of prematurity. J APPOS 2009; 13:504-6. Article

Shah DN, Karp K, Ying GS, Mills MD, Quinn GE. Image analysis of posterior pole vessels identifies type I retinopathy of prematurity. J APPOS 2009; 13:507-8. Article

Volpe NJ, Dadvand L, Kim SK, Maguire MG, Ying GS, Moster ML, Galetta SL, M. D. Computerized Binocular Pupillography of the Swinging  Flashlight Test Detects Afferent Pupillary Defects. Current Eye Research 2009; 34:606-13. Article

Maguire AM, High KA, Auriccho A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli J, Ying GS, Rossi S, Marshall KA, Banfi S, Chung D, Morgan JA, Hauck B, Zelanaia O, Zhu X, Raffini L, Coppieters F, Elfride DB, Schindler K, Volpe N, Surace EM, Acerra C, Lyubarsky A, Redmond TM, Stone E, Sun J, , McDonnell JW, Leroy BP, Simonelli F, Bennett J. Phase I gene therapy shows reversal of congenital blindness: Age-dependent effect of treatment. Lancet 2009; 374;1597-605.

Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang YZ, Friedman DS. Interventions Improve Poor Adherence with Once Daily Glaucoma Medications in Electronically Monitored Patients. Ophthalmology: 2009; 116:2286-93. Article

Simonelli F, Maguire AM, Testa F ,Pierce EA, Mingozzi F, Bennicelli J, Rossi S, Marshall K, Banfi S, Surace EM, Sun J, Redmond M, Zhu X, Shindler KS, Ying GS, Ziviello C, Acerra C, Wright JF, DcDonnel JW, High KA, Bennett J, Auricchio A. Gene therapy for Leber’s congenital amaurosis is safe and effective through 1.5 years after vector administration. Molecular Therapy 2009 Dec 1. [Epub ahead of print].

Mowry EM, Loguidice MJ, Daniels AB, Jacobs DA, MD; Markowitz CE, Galetta SL, Nano-Schiav ML, Cutter GR, Maguire MG, Balcer LJ. Vision-related quality of life in multiple sclerosis: correlation with new measures of low- and high-contrast letter acuity. Neurol Neurosurg Psychiatry 2009; 80:767-72. Epub 2009 Feb 23[PMID: 19240050].

Burkholder BM, Osborne B, Loguidice M, Frohman TC, Conger A, Ratchford JN, Warner C, Markowitz CE, Jacobs DA, Galetta SL, Cutter GR, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM. Macular volume by optical coherence tomography as measure of neuronal loss in multiple sclerosis. Arch Neurol 2009; 66:1366-72. [PMID: 19901168].

2010

Stone RA, Ying GS, Pearson DJ, Dansal M, Puri M, Miller E, Alexander J, Piltz J, Nyberg W, Maguire MG, Eledath J, Sawhney H. Utility of digital stereo images for optic disc evaluation. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5667-74. Epub 2010 May 26. [PMID: 20505199.]

Garcia MM, Ying GS, Cocores CA, Tanaka JC, Komaromy AM. Behavioral test for visual assessment of canine achromatopsia. American Journal of Veterinary Research 2010;71:97-102.

Simonelli F, Maguire AM, Testa F ,Pierce EA, Mingozzi F, Bennicelli J, Rossi S, Marshall K, Banfi S, Surace EM, Sun J, Redmond M, Zhu X, Shindler KS, Ying GS, Ziviello C, Acerra C, Wright JF, DcDonnel JW, High KA, Bennett J, Auricchio A. Gene therapy for Leber’s congenital amaurosis is safe and effective through 1.5 years after vector administration. Molecular Therapy 2010;18:643-50.

Zaida AA, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Throne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH. Hypopyon in patients with uveitis. Ophthalmology 2010;117:366-72.

Ghodasra DH, Karen KA, Ying GS, Mills MD, Wilson C, Fielder AR, Ng J, Quinn GE. Risk stratification of eyes with preplus ROP by semi-automated analysis of digital images. Arch Ophthalmol. 2010;128:719-23.

Talman LS, Sackel D, Long DA, Bisker ER, Ratchford JN, Farrell SK, Loguidice MJ, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ. Longitudinal study of vision and retinal nerve fiber layer thickness in MS. Ann Neurol 2010;67:749-60.

Xu W, Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Martin ER, Dunaief JL, Brucker AJ. Risk factors for choroidal neovascularization in AMD are associated with decreased foveolar choroidal circulation. Am J of Ophthalmol 2010;150:40-47.

Metelitsina TI, Grunwald JE, DuPont JC, Ying GS. Effect of isometric exercise on choroidal blood flow in patients with age-related macular degeneration (AMD). Br J Ophthalmol. 2010 Dec; 94(12):1629-31. doi: 10.1136/bjo.2009.176859. Epub 2010 Sep 13. PMID: 20837789. PMCID: PMC4077432. 

Tamhankar MA, Kim JH, Ying GS, Volpe NJ. Adult hypertropia: a guide to diagnostic evaluation based on review of 300 patients. Eye. 2011 Jan 25(1):91-6. doi: 10.1038/eye.2010.160. Epub 2010 Nov 5. PMID: 21057518. PMCID: PMC3144639

2011

Binenbaum G, Ying GS, Quinn GE, Dreiseitl S, Karp K, Roberts RS, Kirpalani H, and the Premature Infants in Need of Transfusion Study Group. A Clinical prediction model to stratify ROP risk using postnatal weight gain. Pediatrics 2011; 127:607-614. [PMID: 21321036].

Tamhankar MA, Ying GS, Volpe NJ. Success of prisms in the management of diplopia due to fourth nerve palsy. J Neuroophthalmol. 2011 Sep; 31(3):206-9. doi: 10.1097/WNO.0b013e318211daa9. PMID: 21378578. PMCID: PMC4090702.

Shah DN, Wilson CM, Ying GS, Karp KA, Cocker KD, Fielder A, Mill MD, Quinn EQ. Comparison of expert graders to computer assisted image analysis of the retina in Retinopathy of Prematurity. Br J Ophthalmol. 2011; 95:1442-5.

Jensen AK, Ying GS, Huang JY, Karp K, Quinn GE, Binenbaum G. Thrombocytopenia and retinopathy of prematurity. J APPOS 2011, 15(1): e3-34.

Smolen H, Ying GS, Martin ER, Maguire MG.  New grading criteria allow for earlier detection of geographic atrophy in clinical trials. Invest Ophthalmol Vis Sci. 2011 Nov 29; 52(12):9218-25. doi: 10.1167/iovs.11-7493. PMID: 22039251. PMCID:  PMC3302429.

Galetta KM, Barrett J, Allen M, Madda F, Delicata D, Tennant AT, Branas CC, Maguire MG, Messner LV, Devick S, Galetta SL, Balcer LJ. The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters. Neurology 2011;76(17):1456-62.

Pineles SL, Birch EE, Talman LS, Sackel DJ, Frohman EM, Calabresi PA, Galetta SL, Maguire MG, Balcer LJ. One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol. 2011;152(1):133-40.

Avery  RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, Maguire MG, Balcer LJ. Retinal Nerve Fiber Layer Thickness in Children with Optic Pathway Gliomas. Am J Ophthalmol. 2011 Mar; 151(3):542-9.e2. doi: 10.1016/j.ajo.2010.08.046. Epub 2011 Jan 12. PMID: 21232732. PMCID: PMC3053008.

2012

Berenberg TL, Metelitsina TI, Madow B, Dai Y, Ying GS, DuPont JC, Grunwald L, Brucker AJ, Grunwald JE. The association between drusen extent and foveolar choroidal blood flow in age-related macular degeneration. Retina. 2012 Jan; 32(1):25-31. doi: 10.1097/IAE.0b013e3182150483. PMID: 21878837. PMCID: PMC3244536

Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DC, McCague S, Pierce EA, Chen Y, Bennicelli JL, Zhu X, Ying GS, Sun J, Wright JF, Auricchio A, Simonelli F, Shindler KS, Mingozzi F, High KA, Maguire AM. AAV2 gene therapy readministration in three adults with Congenital blindness. Science Translational Medicine 2012, 4:120ra15.

Tamhankar MA, Ying GS, Volpe NJ. Effectiveness of prisms in the management of diplopia in patients due to diverse etiolgies. J Pediatric Ophthalmology & Strabismus 2012;49:222-8.

Mehta SM, Loevner LA, Mikityansky I, Langlotz C, Ying GS, Tamhankar MA, Shindler K, Volpe NJ. The diagnostic and economic yield of neuroimaging in neuro-ophthalmology. J Neuroophthalmol. 2012;32:139-144.

Charkoudian LD, Ying GS, Pujari SS, Gangaputra S, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Kempen JH.  High-dose intravenous corticosteroids for ocular inflammatory diseases.  Ocul Immunol Inflamm. 2012 Apr; 20(2):91-9. doi: 10.3109/09273948.2011.646382. PMID: 22409561. PMCID: PMC3306126.

Hunter A, Spechler PA, Cwanger A, Song Y, Zhang Z, Ying GS, Hunter AK, Dezoeten E, Dunaief JL. DNA methylation is associated with altered gene expression in AMD. Invest Ophthalmol Vis Sci. 2012 Apr 24; 53(4):2089-105. doi: 10.1167/iovs.11-8449. PMID: 22410570. PMCID: PMC4108280

Tamhankar MA, Ying GS, Volpe NJ. Prisms are effective in resolving diplopia from incomitant, large and combined strabismus. Eur J Ophthalmol. 2012;22:890-7.

Kwon JY, Ghodasra DH, Ying GS, Wilson CM, Karp KA, Huang JY, Mills MD, Fielder AR, Quinn GE. Quantitative analysis of retinal vessel parameters following photocoagulation treatment for retinopathy of prematurity. J APPOS 2012;16:350-3.

Khitri MR, Mills MD, Ying GS, Davidson SL, Quinn GE. Visual acuity in pediatric glaucomas. J APPOS 2012;16:376-81.

Wehrli SJ, Tawse K, Levin MH, Zaidi A, Pistilli M, Brucker AJ. A Lack of Delayed Intraocular Pressure Elevation in Patients Treated with Intravitreal Injection of Bevacizumab and Ranibizumab. Retina 2012;32:1295-301.

Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, MD, MPH, Rosenbaum JT, Kempen JH.  Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology. 2012 Aug; 119(8):1569-74. PMID: 2248116. PMCID: PMC3394895

Shindler KS, Revere K, Dutt M, Ying GS, Chung DC. In vivo detection of experimental optic neuritis by pupillometry. Exp Eye Res. 2012 Jul; 100:1-6. PMID: 22561341. PMCID: PMC3923364.

Daniel E, Pistilli M, Pujari SS, Kaçmaz RO, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH.  Risk of Hypotony in Noninfectious Uveitis.  Ophthalmology. 2012 Nov; 119(11):2377-85. PMID: 22796306. PMCID: PMC3475753.

Ghodasa DH, Thuangtong A, Karp K, Ying GS, Mills M, Wilson CM, Fielder AR, Ng J, Quinn GE. The rate of Change in retinal vessel width and tortuosity in eyes at risk for retinopathy of prematurity. J AAPOS 2012;16:431-6.

Binenbaum G, Ying GS, Quinn G, Huang J, Dreiseitl S, Antigua J, Forough N, Abbasi S. The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Archives Ophthalmology 2012;130:1560-5.

Hadziahmetovic M, Paijic M, Grieco S, Song Y, Song D, Li Y, Cwanger A, Iacovelli J, Chu S, Ying GS, Connelly J, Spino M, Dunaief JL. The oral chelator deferiprone protects against retinal degeneration induced through diverse mechanism. Transl Vis Sci Technol. 2012 Oct; 1(3):2. eCollection 2012. PMID: 24049709. PMCID: PMC3763884.

Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, Wilson JA, Maguire MG, Galetta SL, Frohman E, Calabresi PA, Schuman JS, Balcer LJ. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012;119:1250-7.

Wolkow N, Song D, Song Y, Chu S, Hadziahmetovic M, Lee JC, Iacovelli J, Grieco S, Dunaief JL. Ferroxidase hephaestin's cell-autonomous role in the retinal pigment epithelium. Am J Pathol. 2012 Apr; 180(4):1614-24. doi: 10.1016/j.ajpath.2011.12.041. Epub 2012 Feb 17. PMID: 22342521. PMCID: PMC3349827.

Dhingra A, Ramakrishnan H, Neinstein A, Fina ME, Xu Y, Li J, Chung DC, Lyubarsky A, Vardi N. Gß3 is Required for Normal Light ON Responses and Synaptic Maintenance. J Neurosci. 2012 August 15; 32(33): 11343–11355. doi:  10.1523/JNEUROSCI.1436-12.2012. PMID: 22895717. PMCID: PMC3478105

Grunwald JE, Alexander J, Ying GS, Maguire M, Daniel E, Whittock-Martin R, Parker C, McWilliams K, Lo JC, Go A, Townsend R, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek J, Xie D, Jaar BG, The CRIC Study Group. Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol. 2012 Sep; 130(9):1136-44. PMID: 22965589. PMCID:  PMC3719171.

Cohen AM, Cook N, Harris MC, Ying GS, Binenbaum G. Pain Response to Mydriatic Eye Drops in Preterm Infants.  J Perinatology. 2013 Jun; 33(6):462-465. doi: 10.1038/jp.2012.149. Epub 2012 Dec 13. PMCID: PMC3874813.

2013

Brader H, Ying GS, Martin ER, Maguire MG. Characteristics of Incident Geographic Atrophy in the Complications of Age-related macular degeneration Prevention Trial. Ophthalmology 2013;120;1871-9.

Chen SP, Massaro-Giordano G, Pistilli M, Schreiber CA, Bunya VY. Tear Osmolarity and Dry Eye Symptoms in Women Using Oral Contraception and Contact Lenses. Cornea 2013; 32(4):423-8.

Bunya VY, Langelier N, Chen S, Pistilli M, Vivino FB, Massaro-Giordano G. Tear Osmolarity in Sjögren Syndrome. Cornea 2013;32:922-7.

Tamhankar MA, Biousse V, Ying GS, Prasad S, Subramanian PS, Lee MS, Eggenberger E, Moss HE, Pineles S, Bennett J, Osborne B, Volpe NJ, Liu GT, Bruce BB, Newman NJ, Galetta SL, Balcer LJ. Isolated third, fourth and sixth cranial nerve palsies from presumed microvascular versus other causes: A prospective study. Ophthalmology 2013; 120:2264-9.

Binebaum G, Christian CW, Ichord RN, Ying GS, Simon MA, Romero K, Pollock AN, Forbes BJ. Retinal hemorrhage and brain injury patterns on diffusion-weighted magnetic resonance imaging in children with head trauma. J AAPOS 2013, 17:603-8.

Cohen AM, Cook N, Harris MC, Ying GS, Binenbaum G. The pain response to mydriatic eye drops in preterm infants. J. Perinatol. 2013; 33:462-5.

Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH. Risk of Choroidal Neovascularization among the Uveitides. Am J Ophthalmol. 2013; 156:468-77. [PMID: 23795984]. [PMCID: PMC3748230].

Joffe MM, Pistilli M, Kempen JH. Marginal Structural Models for Comparing Alternative Treatment Strategies in Ophthalmology using Observational Data. Ophthalmic Epidemiol. 2013; 20:197-200.

Kasi SK, Tamhankar MA, Pistilli M, Volpe NJ. Effectiveness of medial rectus advancement alone or in combination with resection or lateral rectus recession in the management of consecutive exotropia. J AAPOS. 2013; 17:465-70.

Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema. Ophthalmology 2014; 121:588-95.

Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Factors Predictive of Remission of New-Onset Anterior Uveitis. Ophthalmology 2014; 121:778-84.

Bunya VY, Brainard DH, Daniel E, Massaro-Giordano M, Nyberg W, Windsor EA, Pearson DJ, Huang J, Maguire MG, Stone RA. Assessment of signs of anterior blepharitis using standardized color photographs. Cornea. 2013; 32:1475-82.

Gadaria-Rathod N, Dentone PG, Peskin E, Maguire MG, Moser A, Asbell PA. Red blood cell fatty acid analysis for determining compliance with omega3 supplements in dry eye disease trials. J Ocul Pharmacol Ther. 2013;29:837-41.

Epstein SP, Gadaria-Rathod N, Wei Y, Maguire MG, Asbell PA. HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease. Exp Eye Res. 2013;111:95-104.

Hankenson FC, Ruskoski N, Saun MV, Ying GS, Oh J, Fraser NW. Weight loss and reduced body temperature determine human endpoints in a mouse model of ocular herpesvirus infection. Journal of the American Association for Laboratory Animal Science 2013; 52:277-285.

Shah DN, Huang J, Ying GS, Pietrobon R, O’Brien JM. Trends in female representation in published ophthalmology literature, 2000-2009. Digit J Ophthalmol. 2013;19:50-5.

2014

Stasi K, Goings D, Huang J, Herman L, Pinto F, Addis RC, Klein D, Massaro-Giordano M, Gearhart JD. Optimal Isolation and Xeno-free culture conditions for limbal stem cell function. Invest Ophthalmol Vis Sci. 2014; 55:375-86.

Hornbeak DM, Payal A, Pistilli M, Biswas J, Ganesh SK, Gupta V, Rathinam SR, Davis JL, Kempen JH. Interobserver agreement in clinical grading of vitreous haze using alternative grading scale. Ophthalmology 2014;121:1643-8.

Doty RL, Beals E, Osman A, Dubroff J, Chung I, Leon-Samiento FE, Hurtig H, Ying GS. Suprathreshold odor intensity perception in early-stage Parkinson’s disease. Mov Disord. 2014;29:1208-12.

Doty RL, Gandhi SS, Osman A, Hurtig HI, Pawasarat I, Beals E, Chung I, Dubroff J, Newberg A, Ying GS, Leon-Sarmiento FE. Point pressure sensitivity in early stage Parkinson's disease. Physiol Behav. 2014;138:21- 27.

Fuerst N, Langelier N, Massaro-Giordano M, Pistilli M, Stasi K, Burns C, Cardillo S, Bunya VY. Tear osmolarity and dry eye symptoms in diabetes. Clin Ophthalmol. 2014 Mar 10; 8:507-15. PMID: 24648714. PMCID: PMC3956735.

Aleman TS, Huang J, Garrity ST, Carter ST, Aleman WD, Ying GS, Tamhankar MA. Relationship between optic nerve appearance and retinal nerve fiber layer thickness as explored with spectral domain optical coherence tomography. Transl Vis Sci Technol. 2014;3:4.

Zheng Y, Daniel E, Hunter AA 3rd, Xiao R, Gao J, Li H, Maguire MG, Brainard DH, Gee JC. Landmark matching based retinal image alignment by enforcing sparsity in correspondence matric. Med Image Anal 2014;18:903-13.

Brodie FL, Charlson ES, Aleman TS, Salvo RT, Gewaily DY, Lau MK, Farren ND, Engelhard SB, Pistilli M, Brucker AJ. Obstructive Sleep Apnea and Central Serous Chorioretinopathy. Retina 2015 Feb;35(2):238-43.

Carter SB, Pistilli M, Livingston KG, Gold DR, Volpe NJ, Shindler KS, Liu GT, Tamhankar MA. The role of orbital ultrasonography in distinguishing papilledema from pseudopapilledema. Eye 2014;28:1425-30.

Chen W, Binenbaum G, Karp K, Baumritter A, Pearson DJ, Maguire AM, Quinn, GE. Late recurrence of retinopathy of prematurity after treatment with both intravitreal bevacizumab and laser. J AAPOS. 2014 Aug; 18(4): 402-4. doi: 10.1016/j.jaapos.2014.03.011. Epub 2014 Aug 1. PMCID: PMC4277745.  

Rothman AL, Tran-Viet D, Gustafson KE, Goldstein RF, Maguire MG, Tai V, Sarin N, Tong AY, Huang J, Kupper L, Cotton CM, Freedman SF, Toth CA. Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery. Ophthalmology. 2015 Mar; 122(3): 610-9. doi: 10.1016/j.ophtha.2014.09.022. Epub 2014 Nov 4. PMCID: PMC4339440

2015

Abbasian J, Blair N, Shahidi M, Ying GS, Huang J, Kaufman L, Blair M. Macular optical coherence tomography in patients with unilateral optic nerve hypoplasia. J AAPOS. 2015 Feb; 19(1): 57-61. doi: 10.1016/j.jaapos.2014.10.025. PMCID: PMC4911229.

Beltran WA, Cideciyan AV, Iwabe S, Swider M, Kosyk MS, McDaid K, Martynyuk I, Ying GS, Shaffer J, Deng W-T, Boye SL, Lewin AS, Hauswirth WW, Jacobson SG, Aguirre GD. Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease. Proc Natl Acad Sci USA. 2015 Oct 27; 112(43): E5844-E5853. Epub ahead of print 2015 October 12. doi:10.1073/pnas.1509914112. PMCID: PMC4629324.

Binenbaum G, Christian CW, Guttmann K, Huang J, Ying GS, Forbes BJ. Evaluation of temporal association between vaccinations and retinal hemorrhage in children. JAMA Ophthalmol. 2015; 133: 1261-5. doi: 10.1001/jamaophthalmol.2015.2868. PMCID: PMC4910821.

Brodie FL, Charlson ES, Aleman TS, Salvo RT, Gewaily DY, Lau MK, Farren ND, Engelhard SB, Pistilli M, Brucker AJ. Obstructive Sleep Apnea and Central Serous Chorioretinopathy. Retina 2015 Feb;35(2):238-43.

Bunya VY, Fuerst NM, Pistilli M, McCabe BE, Salvo R, Macchi I, Ying GS, Massaro-Giordano M. Variability of tear osmolarity in patients with dry eye. JAMA Ophthalmology. 2015 Jun; 133(6): 662-7. doi: 10.1001/jamaophthalmol.2015.0429. PMCID: PMC4466048. 

Charlson ES, Sankar PS, Miller-Ellis E, Regina M, Fertig R, Salinas J, Pistilli M, Salowe RJ, Rhodes AL, Merritt WT III, Chua M, Trachtman BT, Gudiseva HV, Collins DW, Cavali VR, Nichols C, Henderer J, Ying GS, Varma R, Jorgenson E, O’Brien JM. The primary open-angle African-American glaucoma genetics study: Baseline demographics. Ophthalmology. 2015 Apr; 122(4): 711-20. doi: 10.1016/j.ophtha.2014.11.015. Epub 2015 Jan 8. PMCID: PMC4372490. [B]

Chavali VR, Diniz B, Huang J, Ying GS, Sadda SR, Stambolian D. Association of OCT-derived drusen measurements with AMD-associated genotypic SNPs in the Amish population. J Clin Med. 2015 Feb; 4(2): 304–317. Published online 2015 Feb 12. doi:  10.3390/jcm4020304. PMCID: PMC4398021.

Geloneck M, Forbes BJ, Shaffer J, Ying GS, Binenbaum G. Ocular complications in children with diabetes mellitus. Ophthalmology. 2015 Dec; 122(12): 2457-2464. doi: 10.1016/j.ophtha.2015.07.010. Epub 2015 Sep 1. PMCID: PMC4769865.

Hunter AA III, Smit-McBride Z, Anderson R, Bordbari MH, Ying GS, Kim ES, Park SS, Telander DG, Dunaief JL, Hjelmeland LM, Morse LS. GSTM1 and GSTM5 genetic polymorphisms and expression in age-related macular degeneration. Curr Eye Res. 2016 Mar; 41(3): 410-6. doi: 10.3109/02713683.2015.1016179. Epub 2015 Apr 21. PMCID: PMC4972491. 

Jensen AK, Coleman C, Stokes D, Ying GS, Huang J, Kuhn I, Binenbaum G. Filter paper-based insulin-like growth factor assay. J AAPOS 2015;19:363-5.

Kothari S, Foster CS, Pistilli M, Liesegang TL, Daniel ED, Sen HN, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Lawrence SD, Kempen JH, Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. The risk of intraocular pressure elevation in pediatric noninfectious uveitis. Ophthalmology. 2015 Oct; 122(10): 1987-2001. doi: 10.1016/j.ophtha.2015.06.041. Epub 2015 Jul 30. PMCID: PMC4581960.

Lerman MA, Lewen MD, Kempen JH, Mills MD. Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors. Am J Ophthalmol. 2015 Jul; 160(1): 193-200.e1. doi: 10.1016/j.ajo.2015.04.016. Epub 2015 Apr 17. PMCID: PMC4945247.

Mehta R, Ying GS, Houston S, Isakova T, Nessel L, Ojo A, Go A, Lash J, Kusek J, Grunwald J, Wolf M; CRIC Study Investigators. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2015;30:1534-41.

Rothman AL, Tran-Viet D, Gustafson KE, Goldstein RF, Maguire MG, Tai V, Sarin N, Tong AY, Huang J, Kupper L, Cotton CM, Freedman SF, Toth CA. Poorer neurodevelopmental outcomes associated with cystoid macular edema identified in preterm infants in the intensive care nursery. Ophthalmology 2015;122:610-9. [PMCID: PMC4339440].

2016

Binenbaum G, Chen W, Huang J, Ying GS, Forbes BJ. The natural history of retinal hemorrhage in pediatric head trauma. J AAPOS 2016; 20: 131-5. PMCID: PMC4839593. 

Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS. Adalimumab for ocular inflammation. Ocul Immunol Inflamm. 2016;22:1-8.

Iwabe S, Ying G-S, Aguirre GD., Beltran WA. Assessment of visual function and retinal structure following acute light exposure in the light sensitive T4R rhodopsin mutant dog. Exp. Eye Res. 2016 Apr 13; 146: 341-353. doi: 10.1016/j.exer.2016.04.006. PMCID: PMC5004782. 

Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD, Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Remission of intermediate uveitis: Incidence and predictive factors. Am J Ophthalmol. 2016 Apr; 164: 110-117.e2. doi: 10.1016/j.ajo.2015.12.034. Epub 2016 Jan 6.  PMCID: PMC4811720. 

Milman T, Ying GS, Pan W, LiVolsi V. Ameloblastoma: 25 Year Experience at a Single Institution. Head Neck Pathol. 2016 Dec; 10(4):513-520. Epub 2016 Jun 7. doi: 10.1007/s12105-016-0734-5. PMID: 27272180.PMCID: PMC5082058.

Pleet A, Sulewski M, Salowe RJ, Fertig R, Salinas J, Rhodes A, Merritt Iii W, Natesh V, Huang J, Gudiseva HV, Collins DW, Chavali VR, Tapino P, Lehman A, Regina-Gigiliotti M, Miller-Ellis E, Sankar P, Ying GS, O'Brien JM. Risk Factors Associated with Progression to Blindness from Primary Open-Angle Glaucoma in an African-American Population. Ophthalmic Epidemiol. 2016 Aug; 23(4):248-56. doi: 10.1080/09286586.2016.1193207. Epub 2016 Jun 27. PMID: 27348239. PMCID: PMC4939437.

Rahimy E, Shahlaee A, Khan MA, Ying GS, Maguire JI, Ho AC, Regillo CD, Hsu J. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema. Am J Ophthalmol. 2016;164:118-27. 

Rayesse N, Rahimy E, Ying GS, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J. Baseline choroidal thickness as a predictor for treatment outcomes in central retinal vein occlusion. Am J Ophthalmol. 2016. 171;47-52. PubMed PMID: 27270363.

Salowe RJ, Sankar P, Miller-Ellis E, Pistilli M, Ying GS, O’Brien JM. The role of ophthalmology departments in overcoming health care disparities. J Epidemiol Res. 2016; 2: 25-28. PMCID: PMC4724872.

Zhou Q, Shaffer J, Ying GS. Pseudodrusen in the fellow eye of patients with unilateral neovascular age-related macular degeneration: A meta-analysis. PLoS One. 2016; 11: e149030. doi: 10.1371/journal.pone.0149030. eCollection 2016. PMCID: PMC4760707.

2017

Aleman TS, Han G, Serrano LW, Fuerst NM, Charlson ES, Pearson DJ, Chung DC, Traband A, Pan W, Ying GS, Bennett J, Maguire AM, Morgan JI. Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study. Ophthalmology. 2017 Mar; 124(3):359-373. doi: 10.1016/j.ophtha.2016.10.022. Epub 2016 Dec 13. PMID: 27986385. PMCID: PMC5319901.

Ashtari M, Nikonova ES, Marshall KA, Young GJ, Aravand P, Pan W, Ying GS, Willett AE, Mahmoudian M, Maguire AM, Bennett J. The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-on RPE65 Clinical Trial Patients. Ophthalmology. 2017 Jun; 124(6):873-883. PMCID: PMC5805133.

Beltran WA, Cideciyan AV, Boye SE, Ye GJ, Iwabe S, Dufour VL, Marinho LF, Swider M, Kosyk MS, Sha J, Boye SL, Peterson JJ, Witherspoon CD, Alexander JJ, Ying GS, Shearman MS, Chulay JD, Hauswirth WW, Gamlin PD, Jacobson SG, Aguirre GD. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations. Mol Ther. 2017 Aug 2; 25(8):1866-1880. doi: 10.1016/j.ymthe.2017.05.004. Epub 2017 May 27. PMID: 28566226. PMCID: PMC5542804. 

Bunya VY, Chen M, Zheng Y, Massaro-Giordano M, Gee J, Daniel E, O'Sullivan R, Smith E, Stone RA, Maguire MG. Development and Evaluation of Semiautomated Quantification of Lissamine Green Staining of the Bulbar Conjunctiva from Digital Images. JAMA Ophthalmol. 2017 Oct 1; 135(10):1078-1085. PMCID: PMC5710489. 

Bunya VY, Iwabe S, Macchi I, Massaro-Giordano M, Pistilli M, Aguirre GD. Tolerability of Topical Tocilizumab Eyedrops in Dogs: A Pilot Study. J Ocul Pharmacol Ther. 2017 Sep; 33(7):519-524. doi: 10.1089/jop.2017.0017. Epub 2017 Jun 26. PMID: 28650215. PMCID: PMC5586155. 

Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group. Risk of Ocular Hypertension in Adults with Noninfectious Uveitis. Ophthalmology 2017 Aug; 124(8):1196-1208. doi: 10.1016/j.ophtha.2017.03.041. Epub 2017 Apr 19. PMID: 28433444. PMCID: PMC5522760.

Danford ID, Verkuil LD, Collins DW, Gudiseva HV, Choi D, Kanu L, Uyhazi K, Lau M, Maguire MG, Grant G, Chavali VRM, O’Brien JM. Characterizing the "POAGome": A bioinformatics-driven approach to primary open-angle glaucoma. 2017 May; 58:89-114. doi: 10.1016/j.preteyeres.2017.02.001. Epub 2017 Feb 20. PMID: 28223208. PMCID: PMC5464971. 

Dedania VS, Zacks DN, Pan W, VanderBeek BL. Testosterone Supplementation and Retinal Vascular Disease. Retina. 2017 Oct 13. doi: 10.1097/IAE.0000000000001869. [Epub ahead of print]. PMID: 29040227. PMCID: PMC5899058. 

Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS. Adalimumab for ocular inflammation. Ocul Immunol Inflamm. 2017 Jun; 25(3):405-412. doi: 10.3109/09273948.2015.1134581. Epub 2016 Mar 22. PMCID: PMC5033708. 

Garrity ST, Pistilli M, Vaphiades MS, Richards NQ, Subramanian PS, Rosa PR, Lam BL, Osborne BJ, Liu GT, Duncan KE, Shin RK, Volpe NJ, Shindler KS, Lee MS, Moster ML, Tracey EH, Cuprill-Nilson SE, Tamhankar MA. Ophthalmic presentation of giant cell arteritis in African-Americans. Eye (Lond). 2017 Jan; 31(1):113-118. doi: 10.1038/eye.2016.199. Epub 2016 Sep 16. PMID: 27636230. PMCID: PMC5233930.

Govorkova MS, Milman T, Ying GS, Pan W, Silkiss RZ. Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study. Ophthal Plast Reconstr Surg. 2017 May 5. [Epub ahead of print]. PMID: 2848176

Jensen AK, Ying GS, Huang J, Quinn GE, Binenbaum G. Postnatal serum insulin-like growth factor I and retinopathy of prematurity. Retina 2017;37:867-872.

Kim BJ, Irwin DJ, Song D, Daniel E, Leveque JD, Raquib AR, Pan W, Ying GS, Aleman TS, Dunaief JL, Grossman M. Optical coherence tomography identifies outer retina thinning in frontotemporal degeneration. Neurology. 2017 Oct 10; 89(15):1604-1611. doi: 10.1212/WNL.0000000000004500. Epub 2017 Sep 8. PMID: 28887373. PMCID: PMC5634666.

OʼSullivan R, Tom LM, Bunya VY, Nyberg WC, Massaro-Giordano M, Daniel E, Smith E, Brainard DH, Gee J, Maguire MG, Stone RA. Use of Crossed Polarizers to Enhance Images of the Eyelids. Cornea. 2017 May; 36(5):631-635. doi: 10.1097/ICO.0000000000001157. PMID: 28257379. PMCID: PMC5374033.

Parikh R, O’Keefe L, Salowe R, Mccoskey M, Pan W, Sankar P, Miller-Ellis E, Addis V, Lehman A, Maguire M, O’Brien JM. Factors Associated with Participation by African Americans in a Study of the Genetics of Glaucoma. Ethn Health. 2017 Jul 1:1-11. doi: 10.1080/13557858.2017.1346189. [Epub ahead of print]. PMID: 28669230. PMCID: PMC5748378. 

Salowe R, O’Keefe L, Merriam S, Lee R, Khachatryan N, Sankar P, Miller-Ellis E, Lehman A, Addis V, Murphy W, Henderer J, Maguire M, O’Brien J. Cost and Yield Considerations when Expanding Recruitment for Genetic Studies:  The Primary Open-Angle African American Glaucoma Genetics Study. BMC Medical Research Methodology. 2017 Jul 14; 17(1):101. doi: 10.1186/s12874-017-0374-9. PMID: 28705151. PMCID: PMC5512952. 

Sarezky D, Orlin SE, Pan W, VanderBeek BL. Trends in Corneal Transplantation in Keratoconus. Cornea. 2017 Feb; 36(2):131-137. doi:  10.1097/ICO.0000000000001083. PMID: 28060057. PMCID: PMC5315534.

Swanson JW, Aleman TS, Xu W, Ying GS, Pan W, Liu GT, Lang SS, Heuer GG, Storm PB, Bartlett SP, Katowitz WR, Taylor JA. Evaluation of Optical Coherence Tomography to Detect Elevated Intracranial Pressure in Children. JAMA Ophthalmol. 2017 Apr 1; 135(4):320-328. PMCID: PMC5470406. [B]

Traband A, Shaffer JA, VanderBeek BL. Systemic Beta-blockers in Neovascular Age-related Macular Degeneration. Retina. 2017 Jan; 37(1): 41-46. doi:  10.1097/IAE.0000000000001226. PMID: 27467380. PMCID: PMC5177514.

Ying GS, Maguire MG, Glynn R, Rosner B. Tutorial on Biostatistics: Linear Regression Analysis of Continuous Correlated Eye Data. Ophthalmic Epidemiol. 2017 Apr; 24(2):130-140. doi: 10.1080/09286586.2016.1259636. Epub 2017 Jan 19. PMID: 28102741. PMCID: PMC559705.

Ying GS, Zhang Q, Lan Y, Li Y, Heitjan DF. Cure modeling in real-time prediction: How much does it help? Contemp Clin Trials. 2017 Aug; 59:30-37. doi: 10.1016/j.cct.2017.05.012. Epub 2017 May 22. PMCID: PMC5571982.

Ying GS, Maguire MG, Glynn R, Rosner B. Tutorial on Biostatistics: Statistical Analysis for Correlated Binary Eye Data. Ophthalmic Epidemiol. 2018 Feb; 25(1):1-12. doi: 10.1080/09286586.2017.1320413. Epub 2017 May 22. PMID: 28532207. PMCID: PMC5986179.

2018

Bavinger JC, Yu Y , VanderBeek BL. Comparative Risk of Endophthalitis after Intravitreal Injections with Bevacizumab, Aflibercept, and Ranibizumab. Retina. 2018 Oct 3. doi: 10.1097/IAE.0000000000002351. [Epub ahead of print]. PMID: 30312260. PMCID: PMC6447490.

Collins DW, Gudiseva HV, Chavali VRM, Trachtman B, Ramakrishnan M, Merritt WT III, Pistilli M, Rossi RA, Blachon S, Sankar PS, Miller-Ellis E, Lehman A, Addis V, O'Brien JM. The MT-CO1 V83I Polymorphism is a Risk Factor for Primary Open-Angle Glaucoma in African American Men. Invest Ophthalmol Vis Sci. 2018 Apr 1; 59(5):1751-1759. PMCID: PMC5886029. 

Huang J, Huang J, Chen Y, Ying GS. Evaluation of Approaches to Analyzing Continuous Correlated Eye Data When Sample Size Is Small. Ophthalmic Epidemiol. 2018 Feb; 25(1):45-54. doi: 10.1080/09286586.2017.1339809. Epub 2017 Sep 11. PMID: 28891730. PMCID: PMC5988240.

Jensen AK, Ying GS, Huang J, Quinn GE, Binenbaum G. Longitudinal study of the association between thrombocytopenia and retinopathy of prematurity. J AAPOS.2018 Apr; 22(2):119-123. doi: 10.1016/j.jaapos.2017.11.009. Epub 2018 Mar 14. PMID: 29548837; NIHMSID:NIHMS957336. PMCID: PMC6625316. 

Kim DH, Addis VM, Pan W, VanderBeek BL. Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma. Ophthalmic Epidemiol. 2019 Feb; 26(1):63-71. Epub 2018 Sep 6. PMID: 30188773. PMCID: PMC6344297.

Kim BJ, Grossman M, Song D, Saludades S, Pan W, Dominguez-Perez S, Dunaief JL, Aleman TS, Ying GS, Jaffe GJ, Ying G-S, Toth CA, Daniel E, Grunwald JE, Martin DF, Maguire MG, the CATT Research Group. Macular morphology and visual acuity in year five of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2019; 126:252-260. Epub 2018 Sep 3. PMID: 30189282 PMCID: PMC6462189 [Available on 2020-02-01].

Lin LY, Zhou Q, Hagstrom S, Maguire MG, Daniel E, Grunwald J, Martin DF, Ying GS, the CATT Research Group. Association of single-nucleotide polymorphisms in age-related macular degeneration with pseudodrusen: Secondary analysis of data from the Comparison of AMD Treatments Trials. JAMA Ophthalmol. 2018 Jun 1; 136(6):682-688. doi: 10.1001/jamaophthalmol.2018.1231. PMID: 29801032 PMCID: PMC6145774.

McCoskey M, Addis V, Goodyear K, Sankar PS, Ying GS, Yu Y, Salowe R, Cui QN, Miller-Ellis E, Maguire M, O Apos Brien JM. Association between Primary Open-Angle Glaucoma and Cognitive Impairment as Measured by the Montreal Cognitive Assessment. Neurodegener Dis. 2018;18(5-6):315-322. doi: 10.1159/000496233. Epub 2019 Mar 20. PMC6459693. 

O'Brien JM, Salowe RJ, Fertig R, Salinas J, Pistilli M, Sankar PS, Miller-Ellis E, Lehman A, Murphy WHA, Homsher M, Gordon K, Ying GS. Family History in the Primary Open-Angle African American Glaucoma Genetics Study Cohort. Am J Ophthalmol. 2018;192:239-247. doi: 10.1016/j.ajo.2018.03.014. Epub 2018 Mar 17.

O'Neil EC, Huang J, Suhler EB, Dunn JP Jr, Perez VL, Gritz DC, McWilliams K, Peskin E, Ying GS, Bunya VY, Maguire MG, Kempen JH. Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial. Br J Ophthalmol. 2018;102(8):1011-1013. doi: 10.1136/bjophthalmol-2017-311610. Epub 2018 Apr 17. PMC6092316.

Song D, Ying GS, Dunaief JL, Bhuyan R, Li Y, Maguire MG, Grunwald JE, Daniel E, Hagstrom S, Martin DF; Comparison of Age-Related Macular Degeneration Treatment Trial Research Group. Association Between Oral Iron Supplementation and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials. Retina. 2018 Aug 28. doi: 10.1097/IAE.0000000000002295. [Epub ahead of print]. PMID: 30157115. PMCID: PMC6395574.

Song JY, Aravand P, Nikonov S, Leo L, Lyubarsky A, Bennicelli JL, Pan J, Wei Z, Shpylchak I, Herrera P, Bennett DJ, Commins N, Maguire AM, Pham J, den Hollander AI, Cremers FPM, Koenekoop RK, Roepman R, Nishina P, Zhou S, Pan W, Ying GS, Aleman TS, de Melo J, McNamara I, Sun J, Mills J, Bennett J. Amelioration of Neurosensory Structure and Function in Animal and Cellular Models of a Congenital Blindness. Mol Ther. 2018 Jun 6;26(6):1581-1593. doi: 10.1016/j.ymthe.2018.03.015. Epub 2018 Mar 21. PMC5986734.

Uyhazi KE, Miano T, Pan W, VanderBeek BL. Association of Novel Oral Antithrombotics With the Risk of Intraocular Bleeding. JAMA Ophthalmol. 2018 Feb 1; 136(2):122-130. doi: 10.1001/jamaophthalmol.2017.5677. PMID: 29242919. PMCID: PMC5838600.

2019

Addis V, Oyeniran E, Daniel E, Salowe R, Zorger R, Lee R, Pistilli M, Maguire M, Cui Q, Miller-Ellis E, O'Brien JM, Sankar PS. Non-physician grader reliability in measuring morphological features of the optic nerve head in stereo digital images. Eye (Lond). 2019 May; 33(5):838-844. doi: 10.1038/s41433-018-0332-8. Epub 2019 Jan 11. PMID: 30635643. PMCID: in process.

Bavinger JC, Yu Y, VanderBeek BL. Comparative Risk of Endophthalmitis after Intravitreal Injection with Bevacizumab, Aflibercept, And Ranibizumab. Retina 2019 Oct;39(10):2004-2011.

Carroll RM, Yu Y, VanderBeek BL. Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edema. Eur J Ophthalmol. 2019 Feb 14:1120672119827856. doi: 10.1177/1120672119827856. [Epub ahead of print]. PMID: 30764665. PMCID: in process. 

Cui QN, Ramakrishnan MS, Gudiseva HV, Collins DW, Pistilli M, Lee R, Addis VM, Lehman A, O’Brien JM. L1c2 mitochondrial haplogroup is associated with increased disease severity in African-American patients with primary open angle glaucoma. J Clin Exp Ophthalmol. 2019, 10(2). pii: 799. doi: 10.4172/2155-9570.1000799. PMCID: PMC6561505.

Cui QN, Gray IN, Yu Y, VanderBeek BL. Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use. Graefes Arch Clin Exp Ophthalmol. 2019 Sep;257(9):1931-1939.

Gudiseva HV, Pistilli M, Salowe R, Singh LN, Collins DW, Cole B, He J, Merriam S, Khachataryan N, Henderer J, Addis V, Cui QN, Sankar PS, Miller-Ellis E, Chavali VRM, Ying GS, Wallace D, O'Brien JM. The association of mitochondrial DNA haplogroups with POAG in African Americans. Exp Eye Res. 2019 Apr;181:85-89. doi: 10.1016/j.exer.2019.01.015. Epub 2019 Jan 15. PMC6443410.

Kim BJ, Grossman M, Song D, Saludades S, Pan W, Dominguez-Perez S, Dunaief JL, Aleman TS, Ying GS, Irwin DJ. Persistent and Progressive Outer Retina Thinning in Frontotemporal Degeneration. Front Neurosci. 2019 Apr 4;13:298. eCollection 2019. PMC6459211.

 Kim DH, Addis VM, Pan W, VanderBeek BL. Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma. Ophthalmic Epidemiol. 2019 Feb;26(1):63-71. Epub 2018 Sep 6. PMC6344297.

Kolomeyer AM, Maguire MG, Pan W, VanderBeek BL. Systemic Beta-Blockers and Risk of Progression to Neovascular Age-Related Macular Degeneration. Retina. 2019 May; 39(5):918-925. doi: 10.1097/IAE.0000000000002059. PMCID: PMC6072622.

Kolomeyer AM, Yu Y, VanderBeek BL. Association of Opioids With Incisional Ocular Surgery. JAMA Ophthalmol. 2019 Nov 1;137(11):1283-1291.

McCoskey M, Addis V, Goodyear K, Sankar PS, Ying GS, Yu Y, Salowe R, Cui QN, Miller-Ellis E, Maguire M, O'Brien, J. Association between Primary Open-Angle Glaucoma and Cognitive Impairment as Measured by the Montreal Cognitive Assessment. Neurodegener Dis 18(5-6): 315-322, Mar 2019. PMID: 30893703 PMCID: PMC6459693 [Available on 2020-03-20].

Meer E, Shindler KS, Yu Y, VanderBeek BL. Adherence to clinical trial Supported Evaluation of Optic Neuritis. Ophthalmic Epidemiol. 2019 May 29:1-8. doi: 10.1080/09286586.2019.1621352. [Epub ahead of print]. PMID: 31140885. PMCID: in process.

VanderBeek BL, Scavelli K, Yu Y. Determinants in initial treatment choice in diabetic macular edema. Ophthalmol Retina. 2019 May 25. pii: S2468-6530(19)30197-6. doi: 10.1016/j.oret.2019.05.016. [Epub ahead of print]. PMID: 31345726. PMCID: in process.

2020

Areaux RG Jr, Orlin SE, Zaidman GW, Kothari K, Wilson LB, Huang J, Ying GS, Binenbaum G. Anatomic and visual outcomes of corneal transplantation during infancy. J AAPOS. 2020 Jun;24(3):134.e1-134.e6.

Bonafede L, Bender L, Shaffer J, Ying GS, Binenbaum G. Refractive change in children with accommodative esotropia.Br J Ophthalmol. 2020 Sep;104(9):1283-1287.

Carroll RM, Yu Y, VanderBeek BL.Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edema. Eur J Ophthalmol. 2020 Jan;30(1):72-80.

Cao K, Kline B, Han Y, Ying GS, Wang NL. Current Evidence of 2019 Novel Coronavirus Disease (COVID-19) Ocular Transmission: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020 Oct 24;2020:7605453.

Chen X, Tai V, McGeehan B, Ying GS, Viehland C, Imperio R, Winter KP, Raynor W, Tran-Viet D, Mangalesh S, Maguire MG, Toth CA; BabySTEPS Group. Repeatability and Reproducibility of Axial and Lateral Measurements on Handheld Optical Coherence Tomography Systems Compared with Tabletop System. Transl Vis Sci Technol. 2020 Oct 21;9(11):25.

Cipollari E, Szapary HJ, Picataggi A, Billheimer JT, Lyssenko CA, Ying GS, Shaw LM, Kling MA, Kaddurah-Daouk R, Rader DJ, Praticò D, Lyssenko NN; Alzheimer’s Disease Metabolomics Consortium. Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease. J Alzheimers Dis. 2020;74(2):563-578.

Dufour VL, Yu Y, Pan W, Ying GS, Aguirre GD, Beltran WA. In-vivo longitudinal changes in thickness of the postnatal canine retina. Exp Eye Res. 2020 Mar;192:107926.

Jain N, Li AL, Yu Y, VanderBeek BL. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort. Br J Ophthalmol. 2020 Aug;104(8):1093-1097.

Kim BJ, Hunter A, Brucker AJ, Hahn P, Gehrs K, Patel A, Edwards AO, Li Y, Khurana RN, Nissim I, Daniel E, Grunwald J, Ying GS, Pistilli M, Maguire MG, Dunaief JL. Orally Administered Alpha Lipoic Acid as a Treatment for Geographic Atrophy: A Randomized Clinical Trial. Ophthalmol Retina. 2020 Sep;4(9):889-898.

Li Y, Yu Y, VanderBeek BL. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy. Eye (Lond). 2020 May;34(5):934-941.

Liu Q, Saifee M, Yu Y, Ying GS, Li S, Zhong H, Gedde SJ, Han Y. Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation. Am J Ophthalmol. 2020 Aug;216:44-54.

Moussa K, Feinstein M, Pekmezci M, Lee JH, Bloomer M, Oldenburg C, Sun Z, Lee RK, Ying GS, Han Y. Histologic Changes Following Continuous Wave and Micropulse Transscleral Cyclophotocoagulation: A Randomized Comparative Study. Transl Vis Sci Technol. 2020 Apr 28;9(5):22.

Ramakrishnan MS, Yu Y, VanderBeek BL. Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial. JAMA Ophthalmol. 2020 Mar 1;138(3):237-242.

Sobrin L, Yu Y, Susarla G, Chan W, Xia T, Kempen JH, Hubbard RA, VanderBeek BL. Risk of Noninfectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database. Ophthalmology. 2020 Nov;127(11):1558-1566.

Sun JQ, McGeehan B, Firn K, Irwin D, Grossman M, Ying GS, Kim BJ. Comparison of the Iowa Reference Algorithm to the Heidelberg Spectralis optical coherence tomography segmentation algorithm. J Biophotonics. 2020 May;13(5):e201960187.

VanderBeek BL, Scavelli K, Yu Y. Determinants in Initial Treatment Choice for Diabetic Macular Edema. Ophthalmol Retina. 2020 Jan;4(1):41-48.

Waldman AT, Lavery AM, Liu GW, Avery RA, Liu GT, Maguire MG, Ying GS, Banwell BL. High- and Low-Contrast Letter Acuity Perception Matures With Age in Normally Sighted Children. J Neuroophthalmol. 2020 Jun;40(2):148-156.

Ying GS, Maguire MG, Glynn RJ, Rosner B. Calculating Sensitivity, Specificity, and Predictive Values for Correlated Eye Data. Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):29.

Ying GS. A Prediction Model for Retinopathy of Prematurity-Is It Ready for Prime Time? JAMA Ophthalmol. 2020 Jan 1;138(1):29-30.

2021

Ammar MJ, Carroll R, Kolomeyer A, Ying GS, Whitehead G, Brucker AJ, Kim BJ. Clinical Utility of Beta-D-Glucan Testing for Endogenous Fungal Chorioretinitis or Endophthalmitis. Retina. 2021 Feb 1;41(2):431-437.

Bunya VY, Maguire MG, Akpek EK, Massaro-Giordano M, Hennessy S, Vivino FB, Gonzales JA, Baer AN, Ying GS. A New Screening Questionnaire to Identify Patients With Dry Eye With a High Likelihood of Having Sjögren Syndrome. Cornea. 2021 Feb 1;40(2):179-187.

Ciner EB, Kulp MT, Pistilli M, Ying GS, Maguire M, Candy TR, Moore B, Quinn G; Vision In Preschoolers - Hyperopia In Preschoolers (VIP-HIP) Study Group. Associations between visual function and magnitude of refractive error for emmetropic to moderately hyperopic 4- and 5-year-old children in the Vision in Preschoolers - Hyperopia in Preschoolers Study. Ophthalmic Physiol Opt. 2021 May;41(3):553-564.

Cole BS, Gudiseva HV, Pistilli M, Salowe R, McHugh CP, Zody MC, Chavali VRM, Ying GS, Moore JH, O'Brien JM. The Role of Genetic Ancestry as a Risk Factor for Primary Open-angle Glaucoma in African Americans. Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):28.

de Alba Campomanes AG, Espinoza Navarro J, Shaffer J, Ying GS, Zepeda-Romero LC, González-Bernal C, Gutierrez-Padilla JA, Schbib VL, Galan MM, Binenbaum G. Postnatal Serum Insulin-Like Growth Factor I and Retinopathy of Prematurity in Latin American Infants. Ophthalmic Epidemiol. 2021 Jun;28(3):213-219.

Dhingra A, Sharp RC, Kim T, Popov AV, Ying GS, Pietrofesa RA, Park K, Christofidou-Solomidou M, Boesze-Battaglia K. Assessment of a Small Molecule Synthetic Lignan in Enhancing Oxidative Balance and Decreasing Lipid Accumulation in Human Retinal Pigment Epithelia. Int J Mol Sci. 2021 May 28;22(11):5764

Farazdaghi MK, Trimboli-Heidler C, Liu GT, Garcia A, Ying GS, Avery RA. Utility of Ultrasound and Optical Coherence Tomography in Differentiating Between Papilledema and Pseudopapilledema in Children. J Neuroophthalmol. 2021 Apr 14. doi: 10.1097/WNO.0000000000001248. Online ahead of print.

Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Whittock-Martin R, Parker-Ostroff C, Jacoby D, Go AS, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek JW, Xie D; CRIC Study investigators. Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study. Br J Ophthalmol. 2021 Feb;105(2):246-252.

Lepore D, Ji MH, Ying GS, Orazi L, Pagliara MM, Quinn GE; FA team of the Italian ROP study Group. Early angiographic signs of retinopathy of prematurity requiring treatment. Eye (Lond). 2021 Jan 19. doi: 10.1038/s41433-020-01305-z. Online ahead of print.

Ma P, Wu Y, Oatts J, Jutima P, Yu Y, Ying GS, Brad K, Tun TA, He M, Aung T, Li S, Yang Y, Han Y. Evaluation of the diagnostic performance of swept-source anterior segment optical coherence tomography in primary angle closure disease. Am J Ophthalmol. 2021 Jul 17:S0002-9394(21)00362-7. doi: 10.1016/j.ajo.2021.06.033. Online ahead of print.

O'Sullivan ML, Ying GS, Mangalesh S, Tai V, Divecha HR, Winter KP, Toth CA, Chen X; BabySTEPS Group. Foveal Differentiation and Inner Retinal Displacement Are Arrested in Extremely Premature Infants. Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):25.

Prakalapakorn SG, Sarin N, Sarin N, McGeehan B, Tran-Viet D, Tai V, Ying GS, Toth CA, Freedman SF. Evaluating the association of clinical factors and optical coherence tomography retinal imaging with axial length and axial length growth among preterm infants. Graefes Arch Clin Exp Ophthalmol. 2021 Mar 29.

Saifee M, Wu J, Liu Y, Ma P, Patlidanon J, Yu Y, Ying GS, Han Y. Development and Validation of Automated Visual Field Report Extraction Platform Using Computer Vision Tools. Front Med (Lausanne). 2021 Apr 29;8:625487. doi: 10.3389/fmed.2021.625487. eCollection 2021.

Song D, Nadelmann J, Yu Y, VanderBeek BL. Association of Retinal Vascular Occlusion With Women Filling a Prescription for Female Hormone Therapy. JAMA Ophthalmol. 2021 Jan 1;139(1):42-48.

VanderBeek BL, Ying GS, Hubbard RA. Survival Analysis vs Longitudinal Modeling With Multiple Imputation-A False Dichotomy. JAMA Ophthalmol. 2021 May 1;139(5):588.

Wang J, Ying GS. Growth Rate of Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Meta-Analysis of Natural History Studies and Implications for Designing Future Trials. Ophthalmic Res. 2021;64(2):205-215.

Ying GS, Maguire MG, Glynn RJ, Rosner B. Tutorial on Biostatistics: Longitudinal Analysis of Correlated Continuous Eye Data. Ophthalmic Epidemiol. 2021 Feb;28(1):3-20.

Ying GS, Maguire MG, Glynn RJ, Rosner B. Tutorial on Biostatistics: Receiver-Operating Characteristic (ROC) Analysis for Correlated Eye Data. Ophthalmic Epidemiol. 2021 May 12:1-11.

Yu K, Ying GS, Vivino FB, Gonzales JA, Massaro-Giordano M, Bunya VY. Preliminary Screening Questionnaire for Sjögren's Syndrome in the Rheumatology Setting. J Clin Rheumatol. 2021 Jun 18. doi: 10.1097/RHU.0000000000001760. Online ahead of print.

Zhang Q, Liu Y, Thanapaisal S, Oatts J, Luo Y, Ying GS, Wang J, McLeod SD, Gedde SJ, Han Y. The Effect of Tube Location on Corneal Endothelial Cells in Patients with Ahmed Glaucoma Valve. Ophthalmology. 2021 Feb;128(2):218-226.

Zhao M, Sun Q, Oatts J, Hu G, Ge L, Zhu B, Fu M, Wang Y, Miao Y, Luo Q, Niu T, Yu Y, Ying GS, Aung T, Xu X, Han Y. Changes in Intraocular Pressure and Angle Structure after Dilation in Primary Angle-Closure Suspects with Visually Significant Cataract. Ophthalmology. 2021 Jan;128(1):39-47.

Close


CAPT Study Publications

Complications of Age-related Macular Degeneration Prevention Trial Research Group. The Complications of Age-related Macular Degeneration Prevention Trial (CAPT): Rationale, design and methodology. Clinical Trials 2004; 1:91-107.

Complications of Age-related Macular Degeneration Prevention Trial Research Group. The Complications of Age-related Macular Degeneration Prevention Trial (CAPT): Rationale, design and methodology. Clinical Trials 2004; 1:1-17. [PMID: 16281465]

Complications of Age-related Macular Degeneration Prevention Trial Research Group. Baseline characteristics, the NEI-VFQ-25, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2004; 111:1307-1316. [PMID: 15234130]

Complications of Age-related Macular Degeneration Prevention Trial Research Group. Laser Treatment in patients with bilateral large drusen: The Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology 2006; 113:1974-1986. [PMID: 17074563]

Maguire MG, Alexander J, Fine SL, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Characteristics of choroidal neovascularization in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2008; 115:1468-1473. Epub 2008 May 15. [PMID: 18486222]

Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Risk Factors for choroidal neovascularization and geographic atrophy in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology 2008; 115:1474-1479. Epub 2008 May 23. [PMID: 18502512]

Ying G-S, Maguire M, Liu C, Antoszyk A, Complications of Age-related Macular Degeneration Prevention Trial Research Group. Night vision symptoms and progression of age-related macular degeneration (AMD) in the Complications of AMD Prevention Trial. Ophthalmology. 2008; 115:1876-82. Epub 2008 July 30 [PMID: 18672295] [PMCID 2600589]

Ying G-S, Maguire MG, Alexander J, Martin RW, Antoszyk AN, Complications of Age-related Macular Degeneration Prevention Trial Research Group. Description of the AREDS 9-step severity scale applied to participants in CAPT. Arch Ophthalmol 2009; 127:1147-51. [PMID 19752423]

Maguire MG, Ying G-S, McCannel C, Liu C, Dai Y, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2009; 116:2381-2385. Epub 2009 Oct.22. [PMID 19850347] [PMCID 2787900] [NIHMS 128128]

Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL; Complications of Age-Related Macular Degeneration Prevention Trial Research Group, Brucker AJ, Orlin A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Kaderli B, Hadley D, Hagstrom SA, Peachey NS, Klein R, Klein BE, Gotoh N, Yamashiro K, Ferris III F, Fagerness JA, Reynolds R, Farrer LA, Kim IK, Miller JW, Cortón M, Carracedo A, Sanchez-Salorio M, Pugh EW, Doheny KF, Brion M, Deangelis MM, Weeks DE, Zack DJ, Chew EY, Heckenlively JR, Yoshimura N, Iyengar SK, Francis PJ, Katsanis N, Seddon JM, Haines JL, Gorin MB, Abecasis GR, Swaroop A. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci 2010; 107:7401-6. Epub 2010 Apr 12.

Ying G-S, Maguire MG, the Complications of Age-related Macular Degeneration Prevention Trial Research Group. Development of a risk score for geographic atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology 2011; 118:332–338. Epub 2010 Aug 27.

Brader HS, Ying G-S, Martin RE, Maguire, MG, Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group. New grading criteria allow for earlier detection of geographic atrophy in clinical trials. Invest Ophthalmol Vis Sci 2011; 52:9218–9225. Epub 2011 Oct 28.

Close


CATT Editorials and Commentary

Martin DF, Maguire MG, Fine SL. Identifying and eliminating the roadblocks to comparative-effectiveness research. N Engl J Med 2010; 363:105-7. Epub 2010 Jun 2.

Martin DF, Maguire MG, Fine SL. Bevacizumab: not as good with more adverse reactions? Response. Clinical and Experimental Ophthalmology 2011; 39:718-720.

Martin DF, Maguire MG, Fine SL. Ranibizumab and bevacizumab for AMD. Authors reply. N Engl J Med 2011; 365:2237.

Grunwald JE. Risk of geographic atrophy in Comparison of Age-related Macular Degeneration Treatments Trials. Authors reply. Ophthalmology. Epub 2014 Mar 7.

Hagstrom S, Ying G-S, Maguire MG, Martin D. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Authors reply. Ophthalmology 2014; 121:e44-5. Epub 2014 May 6.

Martin DF, Fine SL, Maguire MG. Cost-Related Motivations for Research. Letter to the Editor. JAMA 2014; 312:847.

Hagstrom S, Ying GS, Pauer GJ, Huang J, Maguire MG, Martin DF. Endothelial PAS domain-containing protein 1 (EPAS1) gene polymorphisms and response to anti-VEGF therapy in the Comparison of AMD Treatments Trials (CATT). Letter to the Editor. Ophthalmology 2014; 121:1663-4. Epub 2014 May 9.

Ying G-S, Maguire MG. Comparative effectiveness of bevacizumab and ranibizumab in the Comparison of Age-Related Macular Degeneration Treatments Trials. Authors reply. JAMA Ophthalmology. Epub 2015 Mar 26.

Jaffe GJ, the CATT Research Group. Macular morphology and visual acuity in the second year of the comparison of age-related macular degeneration treatments trials. Authors reply. Ophthalmology 2017; 124:e19.

Maguire MG, the CATT Research Group. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology 2017; 124:e33.

Close


CATT Study Publications

2011

The CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011; 364:1897-908. Epub 2011 Apr 28. PMC3157322.

2012

The CATT Research Group. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: 2-year results. Ophthalmology 2012; 119:1388–1398. Epub 2012 May 1. PMC3389193.

Grunwald JE, Daniel E, Ying G-S, Pistilli M, Maguire MG, Alexander J, Whittock-Martin R, Parker CR, Sepielli K, Blodi BA, Martin DF, the CATT Research Group. Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology 2012. Epub 2012 Apr 17. PMC3401277.

DeCroos FC, Toth CA, Stinnett SS, Heydary CS, Burns R, Jaffe GJ, for the CATT Research Group. Optical coherence tomography grading reproducibility during the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology 2012; 119:2549-57. Epub 2012 Aug 28. PMC3631582.

Ying G-S, Huang J. Maguire MG, Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF, the CATT Research Group. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology 2013; 120:122-129. Epub 2012 Oct 6. PMC3536921.

2013

Hagstrom SA, Ying G-S, Pauer GJT, Sturgill-Short GM, Huang J, Callanan DG, Kim IK, Klein ML, Maguire MG, Martin DF, the Comparison of AMD Treatments Trials Research Group. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology 2013; 120:593-9. Epub 2013 Jan 18. PMC 3633658.

Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying G-S, Grunwald JE, Huang J, the CATT Research Group. Macular morphology and visual acuity in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2013; 120:1860-70. Epub 2013 May 03. PMC3737287.

Maguire MG, Daniel E, Shah AR, Grunwald JE, Hagstrom SA, Avery RL, Huang J, Martin RW, Roth DB, Castellarin AA, Bakri SJ, Fine SL, Martin DF, the CATT Research Group. Incidence of choroidal neovascularization in the fellow eye in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology 2013; 120:2033-41. Epub 2013 May 23. PMC3758381.

Grunwald JE, Daniel E, Huang J, Ying G-S, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF, the CATT Research Group. Risk of geographic atrophy in Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology 2014; 121:150-161. Epub 2013 Sep 30. PMC3892560.

Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, Ying G-S, Huang J, Winter K, Hagstrom SA, Maguire MG, the CATT Research Group. Risk of scar in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2014; 121:656-66. Epub 2013 Dec 4. PMC3943618.

2014

Hagstrom SA, Ying G-S, Pauer GJT, Sturgill-Short GM, Huang J, Maguire MG, Martin DF. VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy in the Comparison of AMD Treatments Trials (CATT). JAMA Ophthalmology 2014; 132:521-7. Epub 2014 Mar 20.

Kim BJ, Ying GS, Huang J, Levy N, Maguire MG, and the CATT Research Group. Sporadic visual acuity loss in the Comparison of AMD Treatments Trials (CATT). Am J Ophthalmol 2014; 158:128-135. Epub 2014 Apr 10.

Folgar FA, Jaffe GJ, Ying G-S, Maguire MG, Toth CA, the CATT Research Group. Comparison of optical coherence tomography assessments in in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology 2014;121:1956-1965. Epub 2014 May 15.

Ying G-S, Kim BJ, Maguire MG, Huang J, Daniel E, Jaffe GJ, Grunwald JE, Blinder KJ, Flaxel CJ, Rahhal R, Regillo C, Martin DF, the CATT Research Group. Sustained Visual Acuity Loss in the Comparison of AMD Treatments Trials (CATT). JAMA Ophthalmology 2014;132:915-921. Epub 2014 May 29.

Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, and the CATT Research Group. Delayed Patchy Choroidal Filling in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol. Epub 2014 Jun 17.

Lee JY, Folgar FA, Maguire MG, Ying GS, Toth CA, Martin DF, Jaffe GJ, the CATT Research Group. Outer Retinal Tubulation in the Comparison of Age-related Macular Degneration Treatments Trials (CATT). Ophthalmology. Epub 2014 July 23.

Moja L, Lucenteforte E, Kwag K, Bertele V, Campomori A, Chakravarthy U, Dickersin K, Evans J, Kodjikian L, Lindsley K, Loke Y, Maguire M, Martin DF, Mugelli A, Reeves BC, Rogers CA, Schmucker C, Subramanian ML, D’Amico R, Virgili G. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane Database Syst Rev. 2014 Sep 15;9:CD011230. [Collaborative Paper]

Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL, Fine SL, Maguire MG, the CATT Research Group. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology. Epub 2014 Oct 09.

Grunwald JE, Pistilli M, Ying G-S, Maguire MG, Daniel E, Martin DF, the CATT Research Group. Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2015;122:809-16. Epub 2014 Dec 24.

2015

Meredith TA, McCannel CA, Barr C, Doft B, Peskin E, Maguire MG, Martin DF, Prenner JL, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Postinjection endophthalmitis in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2015;122:817-821. Epub 2015 Jan 15.

Toth CA, DeCroos FC, Ying G-S, Stinnett SS, Heydary CS, Burns R, Maguire M, Martin DF, Jaffe GJ, the CATT Research Group. Identification of fluid on optical coherence tomography by treating ophthalmologists versus a reading center in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Retina 2015; 35:1303–1314. Epub 2015 Feb 12.

Ciulla TA, Ying G-S, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE, Daniel E, Toth CA, the Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Influence of the vitreomacular interface on treatment outcomes in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology 2015;122:1203-11. Epub 2015 Mar 28.

Hagstrom SA, Ying G-S, Maguire MG, Martin DF, the CATT Research Group, Gibson J, Lotery A, Chakravarthy U, the IVAN Study Investigators. VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy in age-related macular degeneration. Ophthalmology 2015;122:1563-1568. Epub 2015 May 28.

Willoughby AS, Ying G-S, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ, the Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Subretinal hyperreflective material in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology 2015;122:1846-1853. Epub 2015 Jul 2.

Ying G-S, Maguire MG, Daniel E, Ferris FL, Jaffe GJ, Grunwald JE, Toth C, Huang J, Martin DF, the CATT Research Group. Association of baseline characteristics and early vision response with two-year outcomes in the Comparison of AMD Treatments Trials. Ophthalmology Epub 2015 Sep 14.

2016

Daniel E, Shaffer J, Ying G-S, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG, the the Comparison of AMD Treatments Trials (CATT) Research Group. Outcomes in eyes with retinal angiomatous proliferation in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2016;123:609-616. Epub 2015 Dec 8. PMC4766028.

Shah N, Maguire MG, Martin DF, Shaffer J, Ying G-S, Grunwald JE, Toth CA, Jaffe GJ, Daniel E, the Comparison of Age-related Macular Degenertaion Treatments Trials Research Group. Angiographic cystoid macular edema and outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2016;123:858-64. Epub 2016 Jan 8. PMC4808340.

Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying G-S, Huang J, Martin DF, Jaffe GJ, the CATT Research Group. Macular morphology and visual acuity in the second year of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2016;123:865-75. Epub 2016 Jan 9. PMC4998967.

Zhou Q, Daniel E, Maguire MG, Grunwald JE, Martin ER, Martin DF, Ying G-S. Pseudodrusen and incidence of late age-related macular degeneration in fellow eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology 2016;123:1530-40. Epub 2016 Apr 1. .

Maguire MG, Ying GS, Jaffe GJ, Toth CA, Daniel E, Grunwald J, Martin DF, Hagstrom SA, the CATT Research Group. Single-nucleotide polymorphisms associated with age-related macular degenerationt and lesion phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials. JAMA Ophthalmol 2016;134:674-681. Epub 2016 Apr 21. PMC5575967.

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology 2016;123:1751-61. Epub 2016 May 1. PMC4958614.

Grunwald JE, Pistilli M, Daniel E, Ying GS, Pan W, Jaffe GJ, Toth CA, Hagstrom SA, Maguire MG, Martin DF, the CATT Research Group. Incidence and growth of geographic atrophy during 5 years of Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2017;124:97-104. Epub 2016 Oct 27. PMC5234734.

Ferris FL III, Maguire MG, Glassman AR, Ying GS, Martin DF. Evaluating effects of switching anti- vascular endothelial growth factor drugs for age-related macular degeneration and diabetic macular edema. JAMA Ophthalmol 2017;135:145-149. Epub 2016 Dec 22. PMC5467458.

2017

Daniel E, Grunwald JE, Kim BJ, Maguire MG, Jaffe GJ, Toth CA, Ferris FL 3rd Martin DF, Shaffer J, Ying GS, the Comparison of Age-Related Degeneration Treatments Trials Research Group. Visual and morphological outcomes in eyes with hard exudates in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology Retina 2017;1:25-33. PMC5467458

Zhou Q, Daniel E, Grunwald JE, Maguire MG, Gewaily D, Martin DF, Ying GS, the CATT Research Group. Association between pseudodrusen and delayed patchy choroidal filling in the comparison of age-related macular degeneration treatments trials. Acta Ophthal 2017;95:e518-520. Epub 2017 Mar 08. PMC5575967.

Maguire MG, Shaffer J, Ying G-S Chakravarty U, Berg K, Bragadóttir R, Decullier E, Huot L, Kodjikian L, Martin DF, Reeves BC, Rogers CA, Schauwvlieghe AME, Schlingemann RO, the Bevacizumab-Ranibizumab International Trials Group. Serious adverse events with bevacizumab or ranibizumab for age-related macular degeneration: Meta-analysis of individual patient data. Ophthalmology Retina 2017 1:375-381. Epub 2017 Apr 13. PMC5640431

Ying GS, Maguire MG, Pan W, Grunwald JE, Daniel E, Jaffe GJ, Toth CA, Hagstrom SA, Martin DF, the CATT Research Group. Baseline predictors for five-year visual acuity outcomes in the Comparison of AMD Treatments Trials. Ophthalmology Retina. Epub 2017 Nov 23.

2018

Toth CA, Tai V, Chiu SJ, Winter K, Sevilla M, Daniel E, Grunwald JE, Jaffe GJ, Martin DF, Ying GS, Pistilli M, Farsiu S, Maguire MG, the CATT Research Group.  Linking OCT, angiographic, and photographic lesion components in neovascular age-related macular degeneration.  Ophthalmology Retina 2018; 2:481-493. Epub 2017 Nov 28.

Daniel E, Pan W, Ying G-S, Kim BJ, Grunwald JE, Ferris FL, Jaffe GJ, Toth CA, Martin DF, Fine SL, Maguire MG, the CATT Research Group. Development and course of scars in the Comparison of Age-related Macular Degenerations Treatments Trials (CATT). Ophthalmology. Epub 2018 Feb 14.

Rahimy E, Ying G-S, Pan W, Hsu J, the CATT Research Group.  Effect of intraocular-lowering medications on neovascular age-related macular degeneration treatment outcomes in the Comparison of Age-related Macular Degeneration Treatment Trials. Retina 2018.  Epub 2018 Mar 5. PMC6123304

Lin, LY. Qiang, Z. Hagstrom,S. Maguire, MG. Daniel, E. Grunwald,JE. Martin, DF. Ying,GS for the CATT Research Group. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration with Pseudodrusen: Secondary Analysis of Data from the Comparison of AMD Treatments Trials. JAMA Ophthalmol. Published online 2018 May 3. doi:10.1001/ jamaophthalmol.2018.1231.

Song D, Ying G-S, Dunaief JL, Bhuyan R, Li Y, Maguire MG, Grunwald JE, Daniel E, Hagstrom S, Martin DF, the CATT Research Group.  Association between oral iron supplementation and retinal or subretinal hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trial.  Retina.  Epub 2018 Aug 28. PMC6462189.

Jaffe GJ, Ying G-S, Toth CA, Daniel E, Grunwald JE, Martin DF, Maguire MG, the CATT Research Group. Macular morphology and visual acuity in year five of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmology 2019;126:252-260. Epub 2018 Sep 3. PMC6462189.

Daniel E, Ying G-S, Kim BJ, Toth CA, Ferris FL, Martin DF, Grunwald JE, Jaffe GJ, Dunaief JL, Pan W, Maguire MG, CATT Research Group. Five-year follow-up of non-fibrotic scars in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology 2019;126:743-751. Epub 2018 Nov 23. PMC6475610.

2019

Toth CA, Tai V, Pistilli M, Chiu SJ, Winter K, Daniel E, Grunwald JE, Jaffe GJ, Martin DF, Ying G-S, Farsiu S, Maguire MG, the CATT Research Group.  Distribution of OCT features within areas of macular atrophy or scar after two years of anti-VEGF treatment for neovascular AMD in CATT. Ophthalmology Retina 2019;3:316-325. Epub 2018 Dec 3. PMC6482846.

Bavinger JC, Ying G-S, Daniel E, Grunwald JE, Maguire MG, the Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. The relationship between cilio-retinal arteries and advanced age-related macular degeneration in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). JAMA Ophthalmol 2019;137:1306-1311. Epub 2019 Sep 12.  PMC6743058.

2020

Scoles D, Ying G-S, Pan W, Hua P, Grunwald JE, Daniel E, Jaffe GJ, Toth CA, Martin DF, Maguire MG, the Comparison of AMD Treatments Trials Research Group.  Characteristics of eyes with good visual acuity at 5 years after initiation of treatment for age-related macular degeneration by not receiving treatment from years 3 to 5. Post hoc analysis of the CATT Randomized Clinical Trial. JAMA Ophthalmol 2020;138:276-284. Epub 2020 Jan 30. PMC7042910.

Daniel E, Maguire MG, Grunwald JE, Toth CA, Jaffe GJ, Martin DF, Ying G-S, the Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.  Incidence and progression of non-geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). JAMA Ophthalmol. 2020;138:510-518.

Evans RN, Reeves BC, Maguire MG, Martin D, Muldrew A, Peto T, Rogers C, Chakravarthy U. Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti-Vascular Endothelial Growth Factor Agents. JAMA Ophthalmol. 2020;138:1043-1051.

Kolomeyer AM, Smith E, Daniel E, Ying G-S, Pan W, Maguire MG, Kim BJ, the CATT Research Group. Beta peripapillary atrophy and geographic atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials. Retina 2021;41:125-134.

2021

Finn AP, Pistilli M, Tai V, Daniel E, Ying G-S, Maguire MG, Grunwald JE, Martin DF, Jaffe GJ, Toth CA, the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group. Localized optical coherence tomography (OCT) baseline precursors of geographic atrophy and fibrotic scar at years 2 and 5 in the Comparison of Age-Related Macular Degeneration Treatments Trials. Am J Ophthalmol. 2021;223:338-347.

Song D, Hua P, VanderBeek B, Dunaief JL, Grunwald JE, Daniel E, Maguire MG, Martin DF, Ying G-S. Systemic medication use and the incidence of geographic atrophy in the Comparison of Age-related Macular Degeneration Treatment Trials (CATT).  Retina 2021;41:1455-1462.

Core JQ, Pistilli M, Daniel E, Grunwald JE, Toth CA, Jaffe GJ, Hua P, Martin DF, Ying GS, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group. Predominantly Persistent Subretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Ophthalmol Retina. 2021 Jun 11:S2468-6530(21)00192-5. doi: 10.1016/j.oret.2021.06.003. Online ahead of print.

 

Close


CNVPT Publications

Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in eyes with large drusen: short term effects seen in a pilot randomized clinical trial. Ophthalmology 1998; 105:11-23. Abstract

Choroidal Neovascularization Prevention Trial Research Group. Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. Ophthalmology. 1998; 105:1364-1372. Abstract

Ho AC. Maguire MG. Yoken J. Lee MS. Shin DS. Javornik NB. Fine SL. Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology 1999; 106:1367-73; discussion 1374. Abstract

Kaiser RS. Berger JW. Maguire MG. Ho AC. Javornik NB. Choroidal Neovascularization Prevention Trial Study Group. Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Archives of Ophthalmology 2001; 119:826-32. Abstract

Prenner JL, Rosenblatt BJ, Tolentino MJ, Ying GS, Javornik NB, Maguire MG, Ho AC; CNVPT Research Group. Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT. Retina 2003; 23:307-14. Abstract

Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology 2003; 110:971-8. Article

Close


e-ROP Study Publications

Publications from the e-ROP Study as of 6/27/2017

  1. Quinn GE on behalf of the e-ROP Cooperative Group. Telemedicine Approaches to Evaluating Acute-phase Retinopathy of Prematurity: Study Design. Ophthalmic Epidemiology 2014;21(4):256–267.[ PMID: 24955738, PCMID: PMC4861056]
  2. Quinn GE, Ying GS, Daniel E, Hildebrand PH, Ells A, Baumritter A, Kemper AR, Schron E, Wade K, for the e-ROP Cooperative Group. Validity of a Telemedicine System for the Evaluation of Acute-Phase Retinopathy of Prematurity. JAMA Ophthalmology 2014; 132:1178-84. [PMID: 24970095, PMCID: PMC4861044]
  3. Kemper AR, Wade KC, Hornik CP, Ying GS, Baumritter A, Quinn GE, for the e-ROP Cooperative Group. Retinopathy of prematurity risk prediction for infants with birth weight less than 1,251 grams. J Pediatr 2015;166(2):257-261, 2015. [PMID: 25449219, PMCID: 4308554]
  4. Ying GS, Quinn GE, Wade KC, Repka MX, Baumritter A, Daniel E for the e-ROP Cooperative Group. Predictors for the Development of Referral-Warranted Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating of Acute-Phase ROP (e-ROP) Study. JAMA Ophthalmology 2015;133(3):304-311. [PMID: 25521746, PMCID: PMC4416963]
  5. Daniel E, Quinn GE, Hildebrand PL, Ells AL, Hubbard GB, Capone A, Martin RW, Ostroff CP, Smith E, Pistilli M, Ying GS for the e-ROP Cooperative Group. A Validated System for Centralized Grading of Retinopathy of Prematurity: Telemedicine Approaches to Evaluating Acute Phase ROP (e-ROP) Study. JAMA Ophthalmol 2015;133:675-82. [PMID: 25811772, PMCID: 4910817]
  6. Wade KC, Pistilli M, Baumritter, A Karp K, Gong A, Kemper AR, Ying GS, Quinn GE on behalf of the e-Retinopathy of Prematurity Study Cooperative Group. Safety of Retinopathy of Prematurity Examination and Imaging in Premature Infants. J Pediatr 2015;167(5):994-1000. [PMID: 26299381, PMCID: PMC4308554].
  7. Kemper AR, Prosser LA, Wade KC, Repka MX, Ying GS, Baumritter A, Quinn GE for the e-ROP Study Cooperative Group. A Comparison of Strategies for Retinopathy of Prematurity Detection: A Microsimulation Study. Pediatrics 137(1):e20152256, 2016.]
  8. Quinn GE, Barr C, Bremer D, Fellows R, Gong A, Hoffman R, Repka MX, Shepard J, Siatkowski RM, Wade K, Ying GS. Changes In Course Of Retinopathy Of Prematurity From 1986 To 2013: Comparison Of Three Studies in the United States. Ophthalmology 2016; 123:1595-1600. [PMID: 27084562, PMCID: PMC4921295.

  9. Karp KA, Baumritter A, Pearson DJ, Pistilli M, Nyquist D, Huynh M, Satnes K, Keith R, Ying GS, Quinn GE for the e-ROP Cooperative Group. Training retinal imagers for Retinopathy of Prematurity (ROP) screening. JAAPOS 2016; 20:214-19. [PMID: 27164425, PMCID: PMC4936410]
  10. Ying GS, VanderVeen D, Daniel E, Quinn GE, Baumritter A for the e-ROP Cooperative Group. Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity in the e-ROP Study. Ophthalmology 2016;123(10):2176-82. [PMID: 27491396, PMCID: PMC5035617]
  11. Quinn GE, Ells A, Capone Jr A, Hubbard GB, Daniel E, Hildebrand PL, Ying GS, on behalf of the e-ROP Cooperative Group. Analysis of Discrepancy between Diagnostic Clinical Examination and Corresponding Evaluation of Digital Images in the e-ROP Study. JAMA Ophthalmol 2016;134(11):1263-1270.
  12. Morrison D, Bothun ED, Ying GS, Daniel E, Baumritter A, Quinn G, for the e-ROP Cooperative Group. Impact of Number and Quality of Retinal Images in a Telemedicine Screening Program for ROP: Results from the e-ROP Study. J AAPOS 2016;20(6):481-485. [PMID: 27702612, PMCID: PMC5156479]
  13. Quinn GE, Ying GS, Repka MX, Siatkowski RM, Hoffman R, Mills MD, Morrison D, Daniel E, Baumritter A, Hildebrand PL, Schron EB, Ells AL, Wade K, Kemper AR. Timely implementation of a retinopathy of prematurity telemedicine system. J AAPOS 2016;20(5):425-430. [PMID: 27651231, PMCID: PMC5086263]
  14. Daniel E, Ying GS, Siatkowski M, Pan W, Smith E, Quinn G, on behalf of the e-ROP Cooperative Group. Intraocular Hemorrhages and Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study. Ophthalmology 2017;124(3):374-381. [PMID:27986386, PMCID: PMC5319900]
  15. Rogers DL, Bremer DL, Fellows RR, Baumritter A, Daniel E, Pistilli M, Ying GS, Quinn GE, on behalf of the e-ROP Cooperative Group. Comparison of strategies for grading retinal images of premature infants for referral warranted retinopathy of prematurity. J AAPOS 2017;21(2):141-145. [PMID: 28336472, PMCID in process]
  16. Gurwin J, Tomlinson LA, Quinn GE, Ying GS, Baumritter A, Binenbaum G. Postnatal growth and Retinopathy of Prematurity (G-ROP) Study Group and the A Tiered Approach to Retinopathy of Prematurity Screening (TARP) Using a Weight Gain Predictive Model and a Telemedicine System. JAMA Ophthalmol. 2017:135(2) 131-136
  17. Ying GS, Pan W, Quinn GE, Daniel E, Repka MX, Baumritter A, on behalf of e-ROP Cooperative Group. Intereye agreement of retinopathy of prematurity from image evaluation in the Telemedicine Approaches to Evaluating of Acute-Phase ROP (e-ROP) Study. Ophthalmology Retina 2017;1(4):347-354. [PMID: 28944318, PMCID: PMC5607452].
  18. Daniel E, Pan W, Quinn GE, Smith E, Baumritter A, Ying GS, on behalf of e-ROP Cooperative Group.  Single Grading vs. Double Grading with Adjudication in the Telemedicine Approaches to Evaluating Acute-phase Retinopathy of Prematurity (e-ROP). J AAPOS. 2018 Feb;22(1):32-37. [PMID: 29274372 PMCID: PMC5826856].
  19. Quinn GE. Ying GS, Pan W, Baumritter A, Daniel E, on behalf of e-ROP Cooperative Group. Detection of potentially severe retinopathy of prematurity on remote image grading. JAMA Ophthalmol. 2017 Sep 1;135(9):982-986. [PMID:28796856; PMCID: PMC6005697].
  20. Wade KC, Ying GS, Baumritter, A, Gong A, Kemper AR, Quinn GE on behalf of the e-ROP Cooperative Group. Factors in premature infants as associated with low risk of developing retinopathy of prematurity. JAMA Ophthalmol 2019;137(2):160-166. [PMID: 30452500 PMCID: PMC6439829].   
  21. Cheng CE, Daniel E, Pan W, Baumritter A, Quinn GE, Ying GS on behalf of the e-ROP Cooperative Group. Plus disease in the Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP) Study: Characteristics, Predictors, and Accuracy of Image Grading. Ophthalmology 2019 Jun;126(6):868-875.
  22. Cheng QE, Quinn GE, Daniel E, Baumritter A, Smith E, Ying GS; e-ROP Cooperative Group. Progression from preplus to plus disease in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study: incidence, timing, and predictors. J AAPOS. 2020 Dec;24(6):354.e1-354.e6. [PMID: 33212296 PMCID: PMC8005407]. 

Close


Presentations at the Association for Research in Vision and Ophthalmology (ARVO):

Ying, GS. Baseline Characteristics, Vision-related Quality of Life, and Their Associations in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Monday, May 6, 2002. Abstract

K.S. Elsner,E.R. Whittock, R.C. Rees, J. Alexander, B. Madjarov. Grading Drusen from Digital Images. Tuesday, May 7, 2002. Abstract

L.S. Schocket, J.E. Grunwald, T.I. Metelitsina, J.DuPont. Foveolar Choroidal Hemodynamics Three Months after Laser Treatment in Early Age-Related Macular Degeneration. Monday, May 05, 2003. Abstract

M.M. Altaweel, B.A. Blodi, J.N. Ver Hoeve. Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) – Evaluation of Retinal Function in Treated versus Control Eyes with Multifocal Electroretinography. Poster Thursday, May 08, 2003. Abstract

E.R. Whittock, K.S. Elsner, J. Alexander, N.B. Javornik, R. Stoltz. Comparison of Evidence of Low-intensity Laser Burns on Immediate Post Treatment Color Photographs and Post Treatment 12-month Angiograms in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). Thursday, May 08, 2003. Abstract

J.E. Grunwald, M. Figueroa, T.I. Metelitsina, L.S. Schocket and J.C. DuPont. Effect of CAPT Laser Treatment on Choroidal Hemodynamics in Age-Related Macular Degeneration (AMD). Poster Tuesday, Apr 27, 2004. Abstract

T.I. Metelitsina, J.E. Grunwald, J.C. DuPont, M.G. Maguire and G.S. Ying. Foveolar Choroidal Blood Flow in Patients with Age–related Macular Degeneration (AMD) Abstract

R.A. Stoltz, G.S. Ying, J. Alexander and the CAPT Study Group. Fundus Features of Untreated Eyes with Visual Acuity Loss in CAPT. Poster Monday, Apr 26, 2004. Abstract

J.A. Sbarbaro, M.G. Maguire and CAPT Study GroupAnnual Changes in Refractive Error Over 3 Years Among Eyes with Early AMD. Poster Tuesday, Apr 27, 2004 Abstract

J. Alexander, K.S. Elsner, N.B. Javornik, E.R. Whittock, M. Brightwell–Arnold, J.L. Duncan, R.A. Stoltz, S.L. Fine and the CAPT Study Group. Characteristics of Exudation in Patients with Bilateral Large Drusen. Poster Tuesday, Apr 27, 2004. Abstract

GS. Ying, C. Liu, M.G. Maguire and the CAPT Research Group. Night-Vision Symptoms as a Risk Factor for Vision Loss and Choroidal Neovascularization (CNV) in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Poster 2005. Abstract

C. Liu, M. Maguire, G.-S. Ying, and CAPT Research Group. Refractive Error in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): Risk of Late AMD and 5-Year Changes
Invest. Ophthalmol. Vis. Sci. 2007 48: Abstract

GS Ying, MG Maguire, J Alexander, RW Martin, AN Antoszyk, The CAPT Research Group. The AREDS 9-Step AMD Severity Scale Applied to Participants in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT): Baseline Classification, Risk of Advanced AMD, and Longitudinal Path Analysis. Poster April 28, 2008. Abstract

Nemani D, Wilson CM, Karp KA, Ying G-S, Maguire M, Prince JB, Ng J, Fielder AR, Mills MM, Quinn GE. Semi-automated digital image analysis for eyes with and without retinopathy of prematurity (ROP). Invest Ophthalmol Vis Sci 2008 49: ARVO E-Abstract 1384.

Maguire MG, Ying G-S. Evaluation of Incident Advanced Age-Related Macular Degeneration and of Progression on the AREDS 9-Step Severity Scale as Surrogate Outcome Measures in Clinical Trials. Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 263.

Bisker E, Chang S, Conger A, Hiermath G, Dai Y, Ying G-S, Maguire M, Frohman E, Clalbresi P, Balcer L. Clinical and Ocular Imaging Characteristics of Eyes With Visual Loss Over Time in Multiple Sclerosis. Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 927.

Ying G-S, Maguire MG, The CAPT Research Group. Development of a Risk Score for Geographic Atrophy (GA) in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).  Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 1662.

Smolen H, Ying G-S, Martin ER, Maguire MG, The CAPT Research Group. Characteristics of Early Geographic Atrophy in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 3915.

Stone RA, Ying G-S, Pearson DJ, Bansal M, Puri M, Miller E, Alexander J, Piltz J, Nyberg W, Maguire MG, Eledath J, Sawhney H. Utility of Digital Stereo Images for Optic Disc Evaluation, Invest Ophthalmol Vis Sci 2009 50: ARVO E-Abstract 5808.

Close


Retinopathy in the Chronic Renal Insufficiency Cohort (RCRIC) Abstract

JE Grunwald, J Alexander, R Whittock, K McWilliams, CA Gadegbeku, JP Lash, JC Lo, R Townsend, CRIC Study Group. Prevalence of Fundus Pathology in the Chronic Renal Insufficiency Cohort. ARVO April 28, 2008. Abstract

Close


VIP Study Group (Earlier Publications)

Ciner EB, Schmidt PP, Orel-Bixler D, Dobson V, Maguire M, Cyert L, Moore B, Schultz J. Vision screening of preschool children: Evaluating the past, looking toward the future. Optom Vision Sci 1998; 75:571-84. Abstract

Ciner EB, Dobson V, Schmidt PP, Allen D, Cyert L, Maguire M, Moore B, Orel-Bixler D, Schultz J. A survey of vision screening policy of preschool children in the United States. Surv Ophthalmol 1999; 43;445-57. Article

Close


Vision in Preschoolers (VIP) Study Publications

Vision In Preschoolers (VIP) Study Group. Visual acuity results in school-aged children and adults: Lea symbols chart versus Bailey-Lovie chart. Optometry & Vision Science. 2003; 80:650-4. Article

Vision In Preschoolers (VIP) Study Group. Threshold visual acuity testing of preschool children using the crowded HOTV acuity test and the Lea symbols acuity test. J AAPOS. 2003; 7:396-9. Abstract

Schmidt PP, Maguire MG, Moore B, Cyert L for the Vision In Preschoolers Study Group. Testability of preschoolers on stereotests used to screen vision disorders. Optometry & Vision Science. 2003; 80:753-757. Article

Vision in Preschoolers (VIP) Study Group. Comparison of Preschool Vision Screening Tests as Administered by Licensed Eye Care Professionals in the Vision In Preschoolers (VIP) Study. Ophthalmology 2004; 111:637-650. Article

The Vision in Preschoolers (VIP) Study Group. Preschool Visual Acuity Screening with HOTV and Lea Symbols: Testability and Between Test Agreement Optometry & Vision Science 2004; 81:678-683. Article

The Vision in Preschoolers (VIP) Study Group. The Electronic Visual Acuity Tester: Testability in Preschool Children. Optometry & Vision Science 2004; 81:238-244. Article

Vision in Preschoolers (VIP) Study Group. Sensitivity of screening tests for detecting VIP-targeted vision disorders when specificity is 94%. Optometry and Vision Science 2005; 82:432-438. Article

The Vision in Preschoolers (VIP) Study Group. Preschool Vision Screening Tests Administered by Nurse Screeners Compared with Lay Screeners in the Vision in Preschoolers Study Investigational Ophthalmology and Visual Science 2005; 46:2639-2648. Article

Cheatham L, Duson A, Qualley P, Biddle M, Haas B, Peskin E, Cyert L, Dobson V, Quinn GE, Schmidt PP. Implementation of a Preschool Vision Screening Program in a Mobile Setting. NHSA Dialog: A Research-to-Practice Journal for the Early Intervention Field 2005; 8:16-24.

Vision in Preschoolers (VIP) Study Group. Random Dot E Stereotest: Testability and Reliability in 3 to 5 Year-Old Children. JAAPOS 2006; 10:507-514. PMC 1884952

Vision in Preschoolers (VIP) Study Group. Children unable to perform screening tests in Vision In Preschoolers Study: proportion with ocular conditions and impact on measures of test accuracy. Invest Ophthalmol Vis Sci 2007; 48:83-87.

Vision in Preschoolers (VIP) Study Group. Impact of confidence number on the screening accuracy of the Retinomax autorefractor. Optom Vis Sci 2007; 84:181-185.

Vision in Preschoolers (VIP) Study Group. Does Assessing Eye Alignment along with Refractive Error or Visual Acuity Increase Sensitivity for Detecting Strabismus in Preschool Vision Screening? Invest Ophthalmol Vis Sci; 2007; 48:3115-3125. PMC 2140241

Kulp MT, Vision in Preschoolers Study Group. Findings from the Vision in Preschoolers (VIP) Study. Optom Vis Sci 2009;86:619-23. Erratum in: Optom Vis Sci 2009; 86:1026. [PMID: 19417714] PMC 2806243

Vision in Preschoolers (VIP) Study Group (Writing team member; Director of the Coordinating Center). Impact of confidence number on the screening accuracy of the SureSight vision screener. Optom Vis Sci 2010; 87:96-103. Epub 2010 Jan 7. NIHMS 181130 PMC 2842082.

Vision in Preschoolers (VIP) Study Group (Writing team member; Director of the Coordinating Center). Age-specific comparisons of the performance of Lea symbols and HOTV optotypes in preschool vision screening. Optom Vis Sci (in press)

Vision in Preschoolers Study Group. Effect of Age Using Lea Symbols or HOTV for Preschool Vision Screening. Optom Vis Sci 2010; 87:87-95.  NIHMS 181128 PMC 2895492.

Vision In Preschoolers (VIP) Study Group. Comparison of the Retinomax and Palm-AR auto-refractors: A pilot study. Optom Vis Sci. 2011; 88:830-6. Epub 2011 Apr 21. PMC 3125429

Ying G-S, Maguire M, Quinn G, Kulp M, Cyert L. ROC Analysis of the accuracy of noncycloplegic retinoscopy, Retinomax autorefractor and SureSight vision screener for preschool vision screening. Invest Ophthalmol Vis Sci 28 2011;52:9658–64. Epub 2011 Nov 28. PMC3341123.

Ying G-S, Huang J, Maguire MG, Quinn G, Kulp MT, Ciner E, Cyert L, Orel-Bixler D, and Vision In Preschoolers (VIP) Study Group. Association of anisometropia with unilateral amblyopia, interocular acuitydifference and stereoacuity in preschoolers. Ophthalmology 2013;120:495-503. PMC3582825.

Huang J, Maguire M, Ciner E, Kulp M, Quinn G, Orel-Bixler D, Cyert L, Moore B, Ying G-S. Inter-tester agreement in refractive error measurements between lay and nurse screener in administering Retinomax autorefractor and SureSight vision screener. Optom Vis Sci 2013; 90:1128-1137. PMC3894690.

Pascual M, Huang J, Maguire MG, Kulp MT, Quinn GE, Ciner E, Cyert LA, Orel-Bixler D, Moore B, Ying G-S, , and the Vision in Preschoolers (VIP) Study Group. Risk factors for amblyopia in the Vision in Preschoolers (VIP) Study. Ophthalmology 2014;121: 622-629. Epub 2013 Oct 18. PMC3943664.

Ying G-S, Maguire M, Ciner E, Cyert L, Kulp MT, Quinn GE, Orel-Bixler D, Moore B, and the Vision in Preschoolers (VIP) Study Group. Prevalence of vision disorders by racial and ethnic group among children participating in Head Start. Ophthalmology 2014; 121:630-6. Epub 2013 Oct 31.

Ciner EB, Ying G-S, Kulp MT, Maguire MG, Quinn GE, Cyert LA, Orel-Bixler D, Moore B, Huang J. Stereoacuity of preschool children with and without vision disorders. Optom Vis Sci 2014 ;91:351-8.

Kulp MT, Ying G-S, Huang J, Maguire M, Quinn GE, Ciner EB, Cyert LA, Orel-Bixler DA, Moore BD. Associations of hyperopia with amblyopia, strabismus, other refractive errors and stereoacuity. Optom Vis Sci. 2014; 91:383-9. Epub 2014 Jan 30.

Kulp MT, Ying G-S, Huang J, Maguire M, Quinn GE, Ciner EB, Cyert LA, Orel-Bixler DA, Moore BD. Accuracy of noncycloplegic retinoscopy, Retinomax autorefractor and SureSight Vision Screener for detecting significant refractive errors. Invest Ophthalmol Vis Sci 2014 6; 55:1378-85. PMC3945898.

Close